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ABSTRACT 
 
Autism spectrum disorders (ASDs) are a group of highly inheritable disorders. 
Genetic testing for ASD is anticipated to be offered in Taiwan in the near future. 
Therefore, it is critical to explore the psychological factors regarding the test decisions 
among the ASD-affected population before the provision of the test. This study 
examined emotions, attitudes, and intention regarding ASD genetic testing among 
parents of children with ASD in Taiwan.  
The purpose of this study was threefold: (i) systematically review the literature 
regarding the emotional responses, attitudes, and intention related to ASD genetic 
testing; (ii) examine the psychological factors, attitudes, and intention regarding ASD 
genetic testing among a sample of parents with autistic children in Taiwan; and (iii) 
utilize structural equation modeling (SEM) analyses to (a) examine the associations 
between the emotional and attitudinal factors that determine parents’ intentions to 
undergo ASD genetic testing and (b) test the overall “fit” of the model.  
The first study systematically synthesized a decade (2003-2013) of empirical 
studies regarding the emotional factors, attitudes, and intention associated with 
undergoing ASD genetic testing and summarized the methodological quality of the 
included articles. This study indicated a lack of literature on this research area as well as 
the gap in the overall quality of the existing studies.  
The second study was an empirical study among 444 parents of children with 
ASD from Taiwan in the preliminary data analysis. A SEM model was employed to 
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analyze the relationship between the variables and test the fit of the theoretical 
framework. This study demonstrated that anxiety, fear, and guilt were all determinants of 
test intention among parents of children with ASD.  
In summary, the findings from this dissertation have direct implications for 
clinicians, psychiatrists, and other health professionals. Specifically, it will (i) help 
explain the potential psychological factors associated with undergoing ASD genetic 
testing, (ii) assist genetic professionals in becoming aware of the existing psychological 
concern, and (iii) help design appropriate pre-test educational programs. Educational 
materials addressing parents’ emotional management should be developed. More 
significantly, policymakers should include and address parents’ opinions properly in the 
official documents.  
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CHAPTER I  
INTRODUCTION 
 
Autism Spectrum Disorder (ASD) genetic testing is a component of clinical 
genetic care and an integral diagnostic tool to evaluate ASD in the United States. It is 
anticipated that similar ASD genetic testing will be provided to patients and their 
families in Taiwan in the foreseeable future, especially in the context of having a 
growing prevalence (12.3‰) among the entire population. Therefore, it is important to 
explore the attitudes and decisions as well as the factors associated with parents’ 
decision-making process with regard to ASD genetic testing. However, to this date, little 
is known in the existing literature about this topic.  
This dissertation examined emotional and attitudinal factors associated with the 
intent to undergo genetic testing for ASD. In a journal format, I presented two self-
contained manuscripts to be submitted for publication in peer-reviewed journals. In the 
first manuscript, I systematically reviewed empirical studies during 2003-2013 that 
assessed emotions, attitudes, and intention with regard to genetic testing for ASD. In the 
second manuscript, I examined the emotional and attitudinal predictors about the 
intention to undergo genetic testing for ASD in a sample of parents of children with 
ASD in Taiwan.  
The dissertation is composed of four chapters and two appendices. Chapter I 
presents an overview of the dissertation, introducing the content that follows. Chapter II 
provides the systematic literature review reporting emotions, attitudes, and intention 
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regarding undergoing autism genetic testing. To date, no systematic literature reviews 
(i.e., reviews that simultaneously summarize studies’ findings and evaluate their quality) 
have been conducted on the topic. To summarize and evaluate the current state of the 
literature on the attitude and intention regarding undergoing autism genetic testing, I 
summarized the existing literature and reported the emotions, attitudes, and intention 
with regard to ASD genetic testing (including the three first-tier tests recommended for 
patients or families with ASD, i.e., Fragile X, G-banded Karyotype, and CMA). Second, 
this review used the methodological assessment to evaluate the quality of the reviewed 
articles by employing a 7-point (quantitative study) and a 6-point (qualitative study) 
criteria, respectively. Four electronic databases were searched using terms such as 
autism genetic testing, Fragile X, Karyotype, and CMA cognition (attitudes or 
perceptions) and decision-making (intention). The final number of studies included in 
this review was 17.  
Chapter III particularly investigates the psychological factors that determine the 
test decisions among a sample of Taiwanese parents of children with ASD. 
Understanding the decisions regarding genetic testing for ASD is expected to have a 
broader impact in Taiwan, primarily due to (i) potential for misuse of genetic testing, (ii) 
the societal pressure or stigmatization associated with having children with mental 
disorders, and (iii) lack of policies or official guidelines to regulate ASD genetic testing. 
To ensure the appropriate use of genetic technology and reduce the concerns regarding 
ASD genetic testing, it is imperative to understand the psychological factors that 
determine the test uptake among parents of children with ASD. 
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For the above-mentioned study, a sample of 444 parents of children was used 
(preliminary data of a paper-and-pencil survey). Based on the current literature on 
factors determining the attitudes, beliefs, and decision-making regarding genetic testing, 
I chose a theoretical model for this study. This model encompassed three kinds of 
constructs, i.e., affect-type variables, attitudes, and intention. The theories used in this 
study included the Theory of Planned Behavior (TPB), Self-Regulation Theory (SRT), 
and the Transactional Model of Stress and Coping (TMSC). The model I chose was 
specifically designed to explain the emotional factors that facilitate or inhibit parents’ 
decisions to undergo genetic testing for ASD. I used structural equation model (SEM) 
analysis to determine whether the observed data supported the hypothesized model.  
Chapter IV presents the conclusion to this dissertation, based on discussions in 
Chapters II and III. Appendix A presents the characteristics of the 17 included studies 
investigating emotional factors, attitudes, and intention regarding autism genetic testing. 
Appendix B contains the matrix of the distributions of emotions, attitudes, and intention 
of undergoing genetic testing among the included 17 articles.  
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CHAPTER II 
A SYSTEMATIC REVIEW OF THE EMOTIONAL RESPONSES, ATTITUDES, 
AND DECISIONS REGARDING THE GENETIC TESTS ASSOCIATED WITH 
AUTISM SPECTRUM DISORDERS 
 
Introduction 
As the number of genetic tests for multifactorial diseases continues to grow in 
clinical settings, individuals and family members at risk for these conditions face more 
and increasingly complex decisions.1 In many instances, decisions to undergo genetic 
tests requires elaborate psychological and behavioral adjustments.2,3 The current 
literature on psychological factors and decisions to undergo genetic testing has been 
heavily centered on (i) cancers as the disease focus, such as hereditary breast, ovarian, 
and colon cancers,4-7 (ii) single-gene disorders with identified etiology, such as Down 
syndrome and Fragile X syndrome,8,9 and (iii) the psychological and behavioral impact 
after genetic testing.10,11 Less attention has been paid to the psychological determinants 
associated with decisions to undergo genetic testing for the complex 
neurodevelopmental disorders, specifically for autism spectrum disorders (ASDs).  
Autism is a range of conditions characterized by social, communicational, and 
behavioral impairments.12 Strong evidence suggests that ASD is among the most 
heritable of all neurodevelopmental conditions with high prevalence (one in sixty-eight 
children) in the United States.13,14 Parents of children with ASD are at an increased risk 
of having another affected pregnancy. The recurrence risk of ASD is between 2-9% if 
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one child was diagnosed with ASD and is 25-35% if two or more affected children were 
identified in one family.15 
Current genetic tests recommended for ASD 
Until recently, there was no single laboratory test, such as the BRCA gene test 
for breast cancer and FMR1 screening for Fragile X,16,17 which can be exclusively used 
for diagnosing ASD. The clinical genetic tests recommended for identifying the etiology 
of ASD vary by medical authorities. American Academy of Neurology and American 
Academy of Pediatrics recommend traditional cytogenetic tests18,19 including G-banded 
karyotyping and Fragile X screening in patients with ASD. Recently, Chromosomal 
microarray technology (CMA) is a relatively novel technology providing higher 
resolution and better diagnostic yield than traditional tests.20 Both the American College 
of Medical Genetics and Genomics (ACMG) and the International Standard Cytogenetic 
Array Consortium recommend CMA as the first-tier test for people affected with ASD.21  
Overall, autism genetic testing can potentially help identify the causes of ASD, 
promote early diagnosis, and develop timely treatment plans.22 As noted by ACMG 
clinical guidelines (2013 revisions), “using current knowledge and technology, a 
thorough clinical genetics evaluation of patients with ASD is estimated to result in an 
identified etiology in 30-40% of individuals.”23(p404) However, similar to other genetic 
tests, autism genetic testing might also involve a number of ethical, legal, and social 
implications, such as genetic discrimination and insurance concerns.24  
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Decisions regarding undergoing autism genetic testing 
The decisions to undergo genetic testing of specific conditions might vary widely 
among at-risk populations.4 Previous literature has shown that the uptake of genetic tests 
were likely to be predicted by a number of psychological factors, such as higher 
perceived disease risk, greater level of anxiety over the disease or desire for emotional 
relief.4,24,25 Unfortunately, psychological factors associated with decisions regarding 
testing for ASD are largely unknown in the existing literature. Decisions to undergo 
autism genetic testing can be more complicated than other conditions due to the 
following reasons: (i) The multifactorial nature of ASD (with more than one single gene 
involved), (ii) the relatively low detection rate with the current technology (compared 
with single-gene disorders, such as Down syndrome and cystic fibrosis), (iii) the 
inability to test for disease severity,26 and (iv) lack of evidence for clinical utility.26,27 
Due to all these test constraints, ASD-affected people, their families, and at-risk 
populations might experience a host of unique psychological factors associated with the 
decision to undergo genetic testing for ASD.24,28 
The purpose of this review was to (i) systematically evaluate a decade of 
empirical literature (2003-2013) regarding the emotional factors, attitudes, and intention 
toward autism genetic testing, including the first-tier genetic tests recommended for 
ASD-affected population (Fragile X, Karyotype, and CMA) and (ii) assess the 
methodological quality of  reviewed studies, including the study design, utilization of 
theory, sample size/sample diversity, data validity, data reliability and trustworthiness. It 
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is critical to assess methodological quality to identify the strength of the existing 
literature and provide useful information for future studies in the topic area.  
Method 
Search strategy and process 
The Garrard’s Matrix method29 guided the procedural framework for this review. 
Key search terms included “autism genetic testing,” “genetic testing for ASD,” the three 
first-tier tests, “Fragile X,” “Karyotype,” and “CMA” for ASD, “cognition” (“attitudes” 
or “perceptions”), and “decision-making” (“intention”). I used various combinations of 
the key terms as well as their variations and Boolean connections. The search process 
comprised three main steps. First, I screened the four primary OVID databases including 
MEDLINE (OVID), EMBASE (OVID), PsycINFO (PROQUEST), and CINAHL 
(Ebsco). All the identified articles from these four databases were exported to RefWorks 
(Refworks Co, Bethesada, MD), a citation management software, for further coding and 
eliminating of duplicates. Second, I assessed the studies that met the inclusion and 
exclusion criteria. Third, I searched Scopus, a database that can search reference lists 
electronically and conducted backward and forward searches. 
Inclusion criteria 
The studies included in this review met the following criteria: (i) they reported 
empirical data related to emotional factors, attitudes, and decisions for undergoing 
genetic testing; (ii) they were published after 2003 (the year in which researchers 
completed the human genome project; (iii) they reported human studies only; and (iv) 
they were published in English. Studies were excluded if (i) they focused on emotional 
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factors, attitudes, or decisions unrelated to undergoing autism genetic testing, such as 
people’s attitudes/decisions after obtaining the genetic test results, as well as treatment 
decisions, clinical decisions, or reproductive decisions; (ii) they focused on health care 
providers’ emotions, attitudes, and intention regarding autism genetic testing; and (iii) 
they were reviews, abstracts, brief reports, commentaries, or letters to the editors. I also 
did not include articles that investigated the psychological well-being and coping 
strategies of having a child or children with genetic disorders such as autism and Fragile 
X syndrome. In addition, studies were excluded if they only examined post-test 
psychological states, such as worries about the test results and anxiety over carrying 
faulty genes.  
Data extraction and synthesis 
Data from the selected articles were extracted and organized into standardized 
matrices by the first author (LX) independently. Appendix A presents the matrix with 
data for each study according to the following categories: first authors, targeted genetic 
tests, recruitment criteria and sample source, sample size, study design, pre-test 
counseling, as well as test uptake/acceptance rate. Appendix B displays each study 
according to the factors we examined in this review, namely, emotional factors, 
attitudes, and intention of undergoing genetic testing. During the data extraction period, 
the first two authors (LX and PG) met to discuss questions or concerns. To assure the 
reliability of the coding process, two of the authors, extracted data from four of the 17 
reviewed studies (approximately 23%) independently and compared their findings. 
Cohen’s kappa (a measure of inter-rater reliability/consistency) was 0.80, indicating 
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adequate inter-rater reliability.30 Differences in ratings were discussed and consensus 
was achieved prior to the final report. 
Methodological quality assessment 
Five criteria were used to assess each reviewed study’s methodological quality. 
Criteria evaluated sample size, response rate, data validity, data reliability, and theory 
use for quantitative studies. Similarly, I assessed sample diversity, data saturation, data 
trustworthiness, research disclosure, and theory use among qualitative studies. All 
studies were assigned a methodological quality score (MQS) with the maximum score of 
7 points (quantitative study) and 6 points (qualitative study), respectively (Table 1).  
Results 
Figure 1 describes the study selection process. Altogether, 2291 articles were 
identified through database searching, of which 503 were duplicates. After eliminating 
duplication, the title and abstracts of 1788 articles were reviewed, resulting in 31 eligible 
studies. After applying the inclusion/exclusion criteria, 17 articles remained. Then I used 
Scopus to screen the references of these selected articles and the articles that referenced 
them. The final sample consisted of 17 articles. Findings are synthesized below in three 
sections and demonstrated in three separate tables: (i) the study characteristics 
(Appendix A), (ii) emotions, attitudes, and intention related to the tests (Appendix B), 
and (iii) methodological quality assessment (Table 1).  
  
 10 
                          
Total articles identified through 
database search  
(n=2291) 
Medline=567 
EMBASE=1377 
PsycInfo=169 
CINAHL=178 
 
Articles screened for review 
through title and abstract 
(n=1788) 
 
Duplicates removed  
(n=503) 
Articles excluded  
(n=1757) 
Full-text articles reviewed 
for eligibility  
(n=31) 
Articles met the 
search criteria  
(n= 17) 
 
Articles included 
from references 
for selected 
articles and 
articles that cited 
them (n=0) 
 
 Final studies 
included  
(n=17) 
Total articles excluded 
            (n= 14) 
Focus on attitudes or intention 
unrelated to undergoing autism 
genetic testing (n=8) 
Focus on health care providers’ 
attitudes and intention regarding 
undergoing autism genetic testing 
(n=1) 
Only abstract (n=5) 
 
 
 
 
Figure 1 Flowchart of selection process. 
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Study characteristics 
Study origins. According to the screening criteria, only studies published since 
2003 were included. All 17 articles in this review were published after 2005. Sixty-five 
percent (n=11) of the studies were published in the past five years; 76.5 % (n=13) of the 
studies were conducted in the United States and the remainder (n=4) in Australia. Barley 
contributed four articles and Skinner17, 31-33 as well as Metcalf34-36 published three 
articles. 
Targeted tests. Two studies (11.8%) specifically targeted autism genetic testing. 
For instance, Chen and colleagues37 recruited 42 parents of children with at least one 
child diagnosed with ASD to explore their awareness and attitudes toward autism genetic 
testing.  
Most studies (88.2%) examined their participants’ perspectives related to genetic 
testing for Fragile X (FX) syndrome. Among 15 studies on FX screening, altogether 60% 
(n=9) examined participants’ attitudes or test intention regarding carrier testing (n=7) or 
prenatal screening (n=2). For example, Anido et al38 conducted a survey among the 
general public exploring its attitudes toward FX carrier testing. Three studies (20%) 
specifically focused on newborn screening. Christie and colleagues39 invited mothers to 
participate in their study about maternal attitudes toward FX newborn screening in the 
postnatal wards. Three studies (20%) investigated the screening in general, including 
three different stages, i.e., carrier, prenatal, and newborn screening. For instance, Skinner 
et al31 investigated caregivers of children with FX syndrome or FX carriers about 
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whether population screening should be offered in preconception, prenatal, and newborn 
stages. 
Recruitment and sample source. Participants in the majority (70.1%, n=12) of 
the studies from the chosen studies were females and the remaining studies (n=5) were 
for both mothers and fathers of children either with FX syndrome or with ASD. More 
than half of the studies (53%, n=9) did not specify the carrier or non-carrier status of 
their samples. For example, Skinner and colleagues17surveyed mothers within 24 hours 
of their newborns’ births, without specifying the mothers’ carrier status. Six studies 
(35.3%) were among an affected population (either the participants were FX carriers or 
had children affected with genetic disorders). Two studies (11.7%) had mixed 
populations, including participants who were both FX carriers and non-carriers.  
Altogether, 41.2% of the studies (n=7) recruited samples from clinical settings, 
such as hospitals or medical centers. For example, Christie and colleagues39 conducted 
research among mothers in a postnatal ward at a children’s hospital in Australia. Five 
studies (29.4%) examined samples from the general population. For instance, Barley and 
colleagues32 recruited families of children with FX and the participants responded to a 
large national survey. Three studies (17.7%) reported their participants were from 
university or national research centers. For example, Anido et al40 enrolled female 
participants from a large research project based at Emory University’s School of 
Medicine. Altogether, two studies (11.8%) used community-based samples. For instance, 
Johnson et al41 used a community-based participatory approach to reach church 
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attendees in various cities and towns in Oklahoma. Narcisa and her colleagues42 
recruited ethnic minorities directly from local or regional autism advocacy groups.  
Sample. The sample size extended from 12 to 29103. Participants’ age ranged 
from 21-89 years. Twelve studies (70.6%) gave detailed information about ethnicity of 
their participants and eight studies (47.1%) were predominantly conducted with a White 
sample. For instance, Barley et al32 reported 92% of the parents in the FX screening 
study were White. As indicated in Chen et al’s study,37 half of their participants were 
ethnic minorities, including African Americans, Hispanics, and Asians. Among the eight 
(47.1%) studies that reported participants’ educational level, most mentioned that more 
than half of their participants received education higher than a college diploma. Six 
(35.3%) studies discussed the annual household income and most of the participants 
from these studies had high annual incomes. For example, Narcisa et al42 reported that 
97.6% of the parents of children with autism had an annual household income higher 
than $50K in their study. 
Study design. Seven (41.2%) studies employed qualitative design, utilizing 
focus groups and semi-structured interviews. Ten (58.8%) studies used quantitative 
design such as questionnaires or surveys. One study by Metcalf and colleagues36 utilized 
both qualitative and quantitative designs. Altogether, three (17.6%) studies relied on 
existing theories to guide their investigations. These theories included Adult Learning 
Theory, Modified Health Belief Model and Grounded Theory. 
Pre-test counseling. Eight studies (47.1%, n=8) provided genetic education and 
counseling to the participants prior to the study in a variety of forms. For instance, as 
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indicated by Anido et al,38 basic disease characteristic and risks were disseminated 
among the mothers who agreed to participate in the FX carrier screening study. The 
contents of the pre-test counseling contained basic disease characteristics and potential 
risks as well as knowledge or information about the tests.  
Test uptake/acceptance rate. Altogether, ten studies (58.8%) reported the 
acceptance rate ranged from 7.9% to 94%. The highest level of consent (94%) was 
reported by Christie et al39 in a study on mothers’ attitudes toward newborn screening for 
FX syndrome. The lowest rate (7.9%) was the acceptance of carrier screening in the 
prenatal genetic counseling setting with a national sample throughout the United 
States.43 Pastore and colleagues44 found more women with diminished ovarian reserve 
(75%) desired to have the FX carrier test than the comparison group with the premature 
ovarian failure or early menopause (43%). Bailey et al33 evaluated a brochure that can 
help with parents’ decisions regarding FX newborn screening; 61.9% parents agreed to 
test their children with the assistance of the information provided by the brochure. 
Emotions, attitudes, and intention 
Emotions. As detailed in Appendix B among the 17 studies, 12 emotions were 
identified. Most of the emotions were adverse psychological conditions, for example, 
anxiety, worry, and fear. The majority of the studies (72.8%, n=14) were conducted 
prospectively, but three (27.2%) were retrospective studies that collected participants’ 
emotional responses after offering the tests to them.  
Anxiety. The most frequently reported emotion was anxiety (29.4%, n=5). For 
example, Archibald and colleagues36 reported carrier testing might cause anxiety during 
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pregnancy and impact future family plans. Christie et al’s 39study claimed that some 
mothers felt anxious about possible test outcomes about newborn screening for FX 
syndrome, although no variability was found based on different social economic status 
or educational levels. Metcalf et al37 identified a reduced anxiety score for women who 
tested for FX syndrome. 
Uncertainty. Five studies (29.4%) mentioned uncertainty. For instance, Christie 
et al39 found that a small number of parents (10/173) encountered uncertainty and 
concern about the consequences of their newborns’ test outcomes with FX syndrome. 
Parents used the words “horrible” or “grief and initial confusion” to describe how they 
might feel about knowing the positive test result about their newborns. Furthermore, 
participants (non-pregnant women) in Archibald et al’s study34 also mentioned the 
uncertainty about the features of FX syndrome might have impacted their test decisions. 
Worry. The emotional factor of worry was mentioned in three studies (17.6%). 
As Barley et al32 discussed, a substantial portion (44.4%) of the parents in their study did 
not want to participate in newborn screening for FX, because they “did not want to 
worry.” Similarly, Skinner and his colleagues17 also found that parents worried about a 
number of negative consequences related to genetic screening for FX; for instance, how 
others might treat them and how they might treat their children. 
Feelings about the parent-child bonding. Three studies (17.6%) described 
feelings about the parent-child bonding, aiming at knowing parents’ attitudes toward 
prenatal screening and newborn screening for FX. All three studies concluded that most 
parents mentioned the bonding with the newborns would not be disrupted. For instance, 
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Christie et al39 found that most respondents (84%) considered the disclosure of a positive 
screening result would not affect parent-newborn bonding. 
Fear. The emotion of fear was discussed in two (11.8%) studies. The specific 
kind of fear mentioned included fear of lacking feedback with regard to the test, fear of 
being discriminated, and fear about the insurance issue.37,41 As Chen et al37 pinpointed, a 
few parents of children with ASD mentioned that they feared that their life insurance 
would be suspended or they would have to pay more if the genetic test showed positive 
results.  
The remaining emotions were only discussed by one study (5.8%). These 
emotions varied among studies and most of them had a negative impact on participants’ 
attitudes and intention regarding undergoing genetic testing. For instance, Pastore and 
colleagues45 reported three emotional responses, i.e., feeling regretful or feeling angry 
about not learning sooner that FX might be related to their infertility and feeling upset if 
FX runs in the family. Anido et al40 reported a “grieving period” among FX-carriers 
prior to pursing the test. Johnson et al41 identified a feeling of distrust was associated 
with participating in FX and other genomics-related research among both Native 
Americans and African Americans. Frustration was how the parents of children with 
ASD in Chen et al’s study37depicted their feeling about the long waiting process for ASD 
genetic testing. The study by Barley et al32 indicated that a high level of depression was 
not associated with caregivers’ opinions about FX population screening. 
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Attitudes. Altogether eight studies investigated participants’ attitudes toward 
undergoing genetic testing. Both positive (41.2%, n=7) and negative attitudes (35.3%, 
n=7) were reported.  
Positive attitudes. All eight studies reporting positive attitudes listed 
participants’ perceived benefits or outcomes pertaining to the test. These perceived 
benefits or outcomes can be categorized into five groups. First, the test might help obtain 
information about parents’ carrier status (29.4%, n=5). Metcalf and his colleagues36 
identified that most test proponents wanted to know both their own health conditions and 
how likely they might have a child with FX syndrome. Second, the test might help with 
reproductive decisions (29.4%, n=5). In the study by Christie and colleagues,39 about two 
thirds of the mothers responded that they would like to use information from the 
newborn screening for FX syndrome when planning for more children. Third, the test 
might help with research (23.5%, n=4). Anido and colleagues38 found participating 
research was the biggest motivator for women who underwent screening toward FX 
carrier testing. Fourth, the test might help with early diagnosis, intervention, and timely 
treatment (23.5%, n=4). Parents in Chen et al’s study37 considered the benefits of having 
their children undergo ASD genetic testing to locate the genetic cause of ASD and to 
obtain timely medical treatment for their affected children, and lastly, parents mentioned 
that the test might help them with better preparation for birth of an affected child 
(17.6%, n=3); for instance, to get more family support or obtain health insurance 
coverage.  
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Negative attitudes. Six studies discussed perceived barriers or concerns related 
to the uptake of the test. These specific barriers were related to (i) concerns related to the 
potential harm brought by undergoing the test (29.4%, n=5); Archibald et al36 mentioned 
the potential emotional impact as well as possible labeling and stigma related to 
undergoing genetic testing for FX syndrome; (ii) concerns related to the characteristics 
of the current tests (11.8%, n=2), such as parents’ questions regarding the existence and 
reliability of the test;36,37 (iii) concerns related to the values of the test (11.8%, n=2). As 
quoted by one mother of children with autism,37(p278) “I mean it [testing] would make no 
difference… it would make no difference in the way the school interacted with him, it 
would not make difference in any of the way he lived”; (iv) concerns about the societal 
implications regarding the genetic test (11.8%, n=2), such as eugenics issues and 
dilemma for people with disabilities and their families;34,36 and lastly, (v) concerns 
related to the religion and culture beliefs (5.9%, n=1). Chen and colleagues38 mentioned 
that religion and culture influence such as destiny played a role in Asian parents’ 
negative attitudes toward genetic testing. 
Intention to undergo genetic testing 
Altogether, nine studies (52.9%) discussed the intention to test and provided the 
reasons for accepting and declining the tests. I categorized the underlying reasons under 
the constructs from Health Belief Model and Theory of Planned Behavior,46,47 i.e., 
perceived benefits, perceived barriers, perceived risk, and subjective norms. Since 
emotions were not included in either of these two dominant health theories, emotional 
factors were added as a separate category.  
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Primary reasons for accepting to undergo testing. The categories of reasons 
for accepting were: (i) Perceived benefits were mentioned in nine studies (52.9%, n=9). 
These perceived benefits were primarily related to early diagnosis, better preparation, 
and informed reproductive decisions. Most women (91.7%) agreed to participate in 
newborn screening tests in Bailey et al’s study,33 and they mentioned that knowing the 
baby’s carrier status with FX could help them prepare better for the possible challenges. 
Narcisa and her colleagues42 found parents wanted to pursue genetic testing for earlier 
diagnosis and closer monitoring of their children with autism. (ii) Perceived risk was 
discussed in four studies. In the investigation by Johnson et al,41 participants favored 
undergoing FX testing due to the perceived risk of passing the genes to the next 
generations. In Bailey et al and Skinner et al’s studies,31,32 participants considered FX 
screening would pose minimal risk. Therefore, they would support undergoing the tests. 
(iii) Subjective norms were identified by three studies. Chen and colleagues37 found that 
recommendations from health care providers and influence by other family members 
could affect the participants’ decisions regarding autism genetic testing. (iv) Perceived 
barriers were discussed by three studies. Metcalf et al36 mentioned that since testing is 
free of charge, the mothers would like to be tested for carrier screening for FX 
syndrome. (v) Emotional factors were listed by one study. Narcisa et al42 reported that 
the possibility of reducing anxiety levels was mentioned as one key reason for parents’ 
interest in testing the younger siblings of their autistic children.  
Primary reasons for declining to undergo testing. As described in Appendix B, 
among the seven studies reporting the primary reasons for declining genetic testing, 
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perceived barriers was the most frequently cited reason (47.1%, n=7).17,33,35-37,41,44 These 
perceived barriers included lack of convenience (29.4%), issues with the current status 
of genetic testing (17.6%), lack of relevance (17.6%), confidentiality (11.8%), bad 
timing (11.8%), issues with the diseases (11.8%), and cost (5.8%). 
The second most cited reason (23.5%, n=4) was the negative emotions associated 
with the test. These emotional factors were “do not want to worry,” “fear,” “lack of 
trust,” and “feeling uncertain.”31,33,35,41 As demonstrated by Bailey et al33 and Skinner et 
al,17 participants considered testing might induce worry; therefore in order to avoid 
worrying, they would decline testing newborns for FX. This viewpoint was echoed in 
another study by Skinner et al31 about parents’ decisions toward population screening for 
FX. The parents of children with FX syndrome rated increased worry as the most likely 
negative outcome with regard to the genetic test for FX syndrome. They worried about 
their child’s future health condition and development as well as the way their children 
might be treated after knowing the test results. Another kind of emotion mentioned by 
Johnson et al41 was fear of lack of feedback and fear of absence of follow-up and 
ostracism. As quoted by one Native-American male participant, “excessive horror 
stories” given by people with previous testing experience terrified him from undergoing 
genetic testing. Lastly, subjective norms, which included lack of encouragement from 
health professionals and culture/family impact, were the concerns raised by three studies 
(17.6%).  
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Methodological quality 
All 17 studies were divided into two broad groups for methodological quality 
assessment, i.e., quantitative studies and qualitative studies. The methodological 
characteristics for quantitative studies included sample size, response rate, data validity, 
data reliability, and utilization of the theoretical framework. In contrast, I measured the 
five aspects of the qualitative studies, i.e., sample diversity, data saturation, data 
trustworthiness, researcher disclosure, and theoretical framework (see Table 1). Metcalf 
et al36reported both qualitative and quantitative data; therefore, I coded the two kinds of 
data separately. The average MQS was 2.56 (SD=1.8; maximum potential score=7) for 
quantitative study and 3.25 (SD=1.4; maximum potential score=6) for qualitative study.  
Quantitative studies. Altogether, 60% (6/10) of the quantitative studies utilized 
large samples (>300). Only one study (10%) reported the response rate. Among the 10 
quantitative studies, two studies reported data validity (content validity) and none of 
them discussed data reliability. Also, none of the studies reported coefficients for the 
data analyzed. None of the quantitative studies reported the utilizing of theoretical 
framework.  
Qualitative studies. A sample diversity measurement included four 
characteristics of the participants: gender, ethnicity, educational level and annual 
household income. If the study included less than two items, then the samples were 
considered homogenous. About 62.5% of the studies (n=5) were categorized into this 
group. Three studies reported more than two characteristics and were, thus, considered to 
be heterogeneous. 
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Table 1 Methodological criteria and frequency distribution of each criterion among the 17 selected articles 
 Quantitative studies    Qualitative studies 
     
     
Methodological 
characteristics 
Scoring options Distribution of 
characteristics 
 
 
 
 
Methodological  
characteristics 
Scoring options Distribution of 
characteristics 
  Frequency  
(n) 
     %     Frequency  
(n) 
      % 
 
Sample size 
 
Small sample (<100)=1 point  
 
3  
 
30% 
   
Sample diversity (i.e., 
gender, ethnicity, 
education level, annual 
household income) 
 
Homogeneous=0 
points  
 
5  
 
62.5% 
 Medium sample (>100 and 
<300)= 2 points 
1 10%    Heterogeneous 
Reported = 1 point 
 
3  37.5% 
 Large sample (>300)= 3 points 6 60% 
 
      
Response rate Not reported =0 point 9 90%   Data Saturation  Not reported=0 points 3  37.5% 
 Reported =1 point 1 10%    Reported= 1 point 5  62.5% 
 
Data validity  
 
Not reported =0 points 
 
 
 
8  
 
80% 
   
Data trustworthiness(e.g., 
triangulation, respondent 
validation, credibility, 
and/or dependability) 
 
Not reported=0 points 
 
1 
 
12.5% 
 Reported=1 point  2 20%    Reported= 1 point 7 87.5% 
Data reliability Not reported =0 points  10 100%   Researcher disclosure Not reported= 0 
points 
7 87.5% 
 Reported=1 point  
 
0  0%    Reported=1 point  1 12.5% 
Theoretical framework  Not reported=0 points 10 100%   Theoretical framework Not reported=0 points 4 50% 
 Reported=1 point 0 0%    Implicit use of 
theories=1 
2 25% 
       Explicit use of 
theories: 
Reported= 2 points 
2 25% 
          
          
Metcalf et al (2008) included both qualitative and quantitative data. The qualitative and quantitative part of the data was coded separately. 
MQS: 2.56 (SD=1.8; Maximum possible score=7 for quantitative study                                                    MQS: 3.25(SD=1.4; Maximum possible score=6) for qualitative study 
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Five studies (62.5%) mentioned their data reached saturation. Most studies 
(87.5%) provided evidence about the methods they used to maintain the credibility of 
their data collection and analysis, including triangulation, member checking, and the 
involvement of more than one person in the data analysis. Reporter disclosure is 
important in qualitative research due to the impact of the potential occurrence of 
researcher bias. Only one study (12.5%) reported this criterion. Two studies (25%) 
mentioned the use of theoretical framework as the guidance for their investigation. 
Researcher bias needs to be noted for giving credit to the studies that reported the use of 
theoretical framework, since qualitative studies usually do not need to have a prior 
theory to guide the investigation. However, I gave credit for studies showing efforts in 
using theoretical framework or validated constructs in the process of data synthesis. 
Discussion 
As the first review explored emotions, attitudes, and intention regarding autism 
genetic testing, this study performed two distinct tasks. First, it synthesized the existing 
literature within the past decade (2003-2013) on the emotions, attitudes, and intention 
with regard to autism genetic testing (including the three first-tier tests recommended for 
patients with ASD, i.e., Fragile X, G-banded Karyotype, and CMA). Second, this review 
used a methodological assessment to evaluate the quality of these studies using either 
qualitative or quantitative methodologies.  
The overall quality assessment of this body of knowledge indicates mixed 
methodological quality. The majority of the quantitative study had a large sample size 
(N>300). However, among the nine quantitative studies, only two reported data’s 
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validity, one mentioned response rate, and none reported data’s reliability. In addition, 
none of these studies utilized a theoretical framework to guide their investigations. 
Therefore, consumers of these studies might have difficulty in assuring the validity and 
reliability of the studies.  
Among the qualitative studies, the majority did not provide the richness and 
nuances of the data by examining at least two characteristics of the sample, such as 
gender, ethnicity, educational level, and annual household income.46,48 Data 
trustworthiness and data saturation were two other crucial indicators of rigorous 
qualitative research.48 The majority in this review provided evidence for these two 
indicators. However, only one study provided the “researcher disclosure”— another 
important indicator for qualitative studies.48 Researcher disclosure is a description of the 
research’s status, such as being part of the community or belonging to the same ethnic 
group as their participants.46 Researcher disclosure can make readers prepare for the 
potential researcher bias. Although qualitative research does not need to be anchored in 
scientific theories, half of the researchers employed a grounded theory approach or other 
validated theories.  
Notably, both in the qualitative and quantitative studies, lack of theoretical 
framework makes it difficult to interpret the relationship of the correlated variables with 
the studies’ outcomes. Recently, official genetics/genomics authorities, such as National 
Human Genome Research Institute, have recommended to expand the existing theories 
for better understanding of the factors that might affect people’s intention to undergo 
genetic testing.49,50 However, only one study in this review mentioned the use of 
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modified constructs from the Health Belief Model (HBM) to explain factors that might 
influence the decision-making process regarding screening. Another study mentioned 
Adult Learning Theory as its framework, because researchers postulated that women in 
FX screening programs might be unprepared and would need a significant amount of 
information about this disease and the screening. The remainders either implicitly 
articulated their theoretical rationale or simply ignored using theories to guide their 
investigations. It is also worth mentioning that, in this review, I intended to categorize 
the major factors that affect test decisions into the key constructs from the well-
established health theories, such as HBM and TPB. These theories, however, did not 
contain a category under which emotions can be classified. Given the neglect of theories 
and emotional construct in explaining intention to undergo genetic testing, future 
researchers should consider adding emotional factors as a construct to their theoretical 
framework for exploring how emotions might affect genetic testing decisions.  
In synthesizing the literature, I identified a few significant literature gaps: (i) the 
limited studies that have explored the associations between emotional factors and the test 
decisions, (ii) the limited studies that have focused on the attitudes and intention 
regarding autism genetic testing among the ASD affected population, and (iii) the lack of 
pre-test counseling or educational efforts for alleviating participants’ negative emotions 
related to testing.  
The most salient finding was the limited studies on exploring the associations 
between emotional factors and the test intention. The inattention to this kind of research 
might be partially attributed to the neglect of emotional factors for explaining genetic 
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testing or screening behaviors.51-53 The studies that investigated decisions to undergo 
genetic testing were either non-theory-based or primarily based on value-expectancy 
theories, such as the HBM and the TPB.51 However, emotional factors, such as fear and 
anxiety, were not adequately taken into consideration, given these theories did not 
emphasize emotions as predictors.46,52  
Another reason for the literature gap might be due to lack of benchmarks or 
criteria for assessing emotional factors related to the uptake of autism genetic testing, 
specifically. Compared to a significant body of research that takes into account 
evaluating emotional responses to genetic tests for Huntington’s Disease or inherited 
cancers7,16,53,54 there were no similar studies of emotional responses to autism genetic 
testing. Official recommendations have been consistently emphasizing testing 
psychological states related to the uptake of cancer-related tests, which may have led to 
the proliferation of such studies related to cancers of various kinds.5 Nevertheless, 
similar recommendations for autism genetic testing are not available. Hill and colleagues 
conducted a systematic literature review exploring psychosocial aspects related to the 
uptake of FX screening and mutation frequency.9Although this review demonstrated 
psychosocial beings with regard to the screening for FX syndrome, it was not designed 
to explore the emotional factors and attitudes that determine participants’ decisions 
associated with FX test decisions. 
With the development of more accurate autism genetic tests for clinical use,20 one 
needs to understand the emotional factors associated with the decisions to undergo these 
tests. As indicated by Gooding and colleagues,51 understanding the factors that 
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determine genetic testing decision-making processes can help with informed choices 
about the test uptake among at-risk patients. This review suggested an immediate need 
for empirical studies to add “emotions” as a component in determining decisions related 
to genetic testing. Specifically, health education efforts or counseling services should 
also consider how to alleviate the influence of negative emotions related to autism 
genetic testing, thus helping maximizing genetic testing utilization.  
Notably, among the studies that reported “emotions,” some used retrospective 
designs, either collecting data immediately after the test, or after the test results had been 
disseminated. These studies asked participants to recall their testing experiences after 
receiving the test results and give the reasons for taking or not taking the tests. Because 
participants were asked about their post-testing attitudes and feelings, the answers 
provided by the participants might not have been the same as if they were asked before 
testing. For instance, anxiety might only last for a short duration at the time of 
occurrence.5 If one wants to know the pre-test emotional factors that affect the decisions 
to take the test, a prospective research design might provide more accurate information. 
Retrospective studies might yield a substantial amount of measurement error.  
Another important finding was the limited studies on the attitudes and intention 
to undergo autism genetic testing among the ASD affected population. Surprisingly, most 
studies focused on the attitudes and intention about undergoing FX screening among the 
general population or those affected with the FX syndrome. Only two studies 
particularly explored the attitudes and intention toward autism genetic testing among 
parents of children with ASD. Prior studies showed that FX screening is associated with 
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ASD and accounts for 2% of ASD cases; therefore, FX screening has been used as a 
standard genetic test among patients with ASD.21 However, none of the FX screening 
studies were conducted among patients or families affected with ASD; specifically, this 
phenomenon could be due to a number of reasons: (i) the constraints of the current tests 
to identify ASD,28 (ii) the lack of consensus regarding clinical utility of these tests, and 
(iii) the multifactorial nature of ASD.21 For example, unlike most genetic screenings for 
single gene disorders, such as Down syndrome and cystic fibrosis, the range of 
diagnostic yield for autism genetic testing ASD is limited to 0.5 to 18%.21,54,55  
The third salient finding is related to pre-test counseling or educational efforts. 
Half of the studies provided rigorously-designed consent and educational materials 
covering the basic characteristics and knowledge/information about the diseases and the 
genetic tests. However, the review showed that the participants might not fully digest the 
information or comprehend the personal, familial, and social impacts related to the test, 
especially the benefits or potential harms of undergoing the test31,38 Moreover, none of 
the studies mentioned any educational interventions for alleviating participants’ 
psychological stress, and/or negative emotions, prior to the test. It is crucial for 
participants to be prepared emotionally for undergoing testing, getting ready for having 
the test results, and making behavioral changes based on the test results.11,55 As indicated 
by Broadstock et al,56pre-test emotional evaluation is necessary for more targeted 
counseling services by health professionals. Therefore, genetic testing research should 
consider including a pre-test evaluation of emotional factors so that the genetic 
counseling can be timely implemented.  
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Additionally, this review found that most studies were conducted among samples 
of White patients/people. Among the limited studies that recruited ethnic minorities, 
variations among attitudes were identified between Caucasian and other ethnic groups. 
As Skinner et al17 identified, African American participants tended to be less likely to 
accept screenings for FX compared with their White counterparts. Johnson and 
colleagues41 purposely recruited Native Americans and African Americans in their study 
and contended that these minority groups appeared to be more hesitant to undergo 
genetic testing. These findings were in line with recent research on the attitudes toward 
genetic testing conducted in the United States that showed variability in viewpoints 
among ethnic minorities. Future research in autism genetic testing should consider 
investigating a wide spectrum of ethnicities to specifically address this role of ethnicity 
and culture in genetic-related inequities.  
Moreover, the majority of the studies identified that the participants had positive 
attitudes toward genetic testing for ASD and FX syndrome.17,42 In addition, the studies 
also documented a high acceptance rate that indicated participants’ willingness to 
undergo the tests or the actual uptake of the tests. For example, Skinner and 
colleagues17,31 identified a generally favorable attitude toward population screening for 
FX. However, their study reported that carrier testing was more acceptable than prenatal 
and newborn tests. This finding was consistent with other studies showing that the 
general public holds positive attitudes toward genetic testing for various conditions.57,58 
However, as pinpointed by Bailey et al,32 timing of the testing, in other words, in which 
stage of the participants’ life genetic testing is offered, was an important factor that 
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might influence the attitudes and decisions with testing. Considering the impact of stages 
of life on testing decisions, screening might need to be offered multiple times to 
facilitate better informed decisions.  
In light of these findings and their implications, I have the following 
recommendations for future studies. First, future studies should investigate various 
factors associated with decisions regarding autism genetic testing. More recently, 
researchers started to make attempts to understand different stakeholders’ perspectives 
related to genetic tests for ASD.28,59 For instance, Reiff and colleagues59researched the 
perspectives of receiving the genetic testing results for CMA among health care 
providers and the patients in clinical settings. Another study by Bernhardt et al60 focused 
on investigating women’s experiences receiving their abnormal test results for CMA. 
However, since these studies either only discussed the after-test scenarios or focused on 
health care providers’ attitudes toward genetic testing associated with ASD, I did not 
report these studies in this review. Given the absence of studies investigating decisions 
to undergo autism genetic testing among ASD-affected populations prior to the offering 
of the test, future research needs to consider investigating this issue. Second, future 
studies should consider (i) utilizing a theoretical framework to guide investigations, (ii) 
reporting the validity and reliability of the data, (iii) considering measuring the 
relationship between emotional factors and decisions to test, and (iv) increasing the ratio 
of ethnic minorities in study samples. 
This review has two limitations. First, although I conducted an exhaustive search 
for relevant articles, I might have overlooked articles in the field due to the constraints of 
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the search terms. Second, I limited my search to empirical studies published in English; 
therefore, selection bias might have occurred and I might have missed articles published 
in other languages. However, the strength of this study is that it is the first review 
reporting the emotions, attitudes, and intention regarding autism genetic testing among 
the at-risk groups and the general population. I provided useful information for more 
rigorous research addressing this topic in the future.  
This review indicated that I did not have sufficient evidence on the associations 
between emotional factors and decisions with regard to undergoing autism genetic 
testing. Also, theoretical framework is largely missing in most of the included studies in 
this review, which makes it difficult to interpret the relationship of the psychological 
variables and other correlated variables. Future studies need to consider using validated 
or self-synthesized theories to explore how emotional factors, attitudes, and decisions 
interact with each other among at-risk populations with ASD. The findings of this review 
have significant implications for genetic education and genetic counseling among 
populations, both affected and non-affected groups. Pre-test health education/genetic 
counseling should address the emotional responses and possible test outcomes associated 
with genetic testing for ASD among patients and families. Health professionals will need 
to carefully consider educating, counseling, or supporting parents of children with ASD 
and thus assisting them with making decisions about genetic testing for ASD.  
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CHAPTER III 
AUTISM GENETIC TESTING: PSYCHOLOGICAL FACTORS ASSOCIATED 
WITH THE TEST DECISIONS AMONG PARENTS OF CHILDREN WITH 
AUTISM SPECTRUM DISORDERS (ASDs) IN TAIWAN 
 
Introduction 
As genetic technologies continue to advance in the post-genomics era, more 
genetic tests for Autism Spectrum Disorders (ASDs) have been used to predict the risk 
of developing ASD, provide information for early diagnosis, and open venues for timely 
medical interventions.61-64 In the United States, although the official guidelines for 
genetic testing for ASD vary by medical authorities, a growing trend is the offering of 
more advanced genetic tests for patients and their families with ASD in clinical 
settings.20 For instance, the American College of Medical Genetics and Genomics 
(ACMG) is currently recommending Chromosomal Microarray Analysis (CMA), a more 
robust technology, among patients with ASD to identify ASD-associated genes.23 In a 
recent study, Australian researchers announced that they have developed a more accurate 
genetic test (detection rate: 70%) to assess the risk for having ASD, particularly among 
people with a family history of ASD or related conditions.65 Additionally, a French bio-
company, IntegraGen, is trying to establish clinical evidence for a novel genetic test 
among hundreds of patients with ASD. Although still extensively debated, direct-to-
consumer (DTC) genetic testing for genetic susceptibility to ASD is already under 
development.26 
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Albeit genetic tests are currently available for ASD-affected populations, 
deciding to undergo autism genetic testing can be a challenging task for parents of 
children with ASD. The reasons might include the nature of this multifactorial disease 
(with a wide spectrum and different severity levels), the unclear clinical significance, the 
ambiguous interpretation of the test results, as well as a number of ethical, social, and 
legal questions pertaining to the test.24,28,66 Given these conditions, it is more urgent to 
understand how affected individuals and their families view autism genetic testing and 
how their affective and cognitive perceptions might impact their decisions.  
Multiple lines of studies in various diseases have explored factors that might 
determine people’s decisions associated with the uptake of genetic testing, such as 
perceived severity, perceived barriers, perceived benefits, attitudes, and intention.51,67,68 
These factors were primarily illustrated in two validated health theories: Theory of 
Planned Behavior (TPB) and Health Belief Model (HBM).51 As Robert and colleagues69 
claimed, based on the key constructs of the HBM, those who believed the benefits of 
testing outweighed the harms tend to be more interested in learning the risks for having 
Alzheimer’s disease. Stein et al70 identified that intention to undergo genetic testing for 
cervical cancer were best predicted by beliefs about the susceptibility of the disease 
conditions. In addition, a prior study systematically reviewed how individuals’ positive 
attitudes were correlated with their intention to be tested for colorectal and 
breast/ovarian cancer.51 Although evidence has shown that psychological factors might 
be an important factor to predict genetic testing decisions, the affect-type variables have 
been largely neglected in the well-established health theories.52 
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Despite the fact less frequently adopted for genetic testing research, two theories, 
the Common Sense Model of Regulation (CSM) and the Transactional Model of Stress 
and Coping (TMSC), have been validated and used to explain how individuals might 
exhibit emotional responses, such as stress and fear as well as how they might cope with 
emotional distress.51,71,72 Theories of stress and coping are well suited for decisions to 
undergo genetic testing because they emphasize how to cope with people’s cognitive and 
emotional concerns.73 Researchers have used both CSM and TMSC to investigate how 
emotional factors might influence the intention to undergo genetic testing for various 
genetic conditions, such as Huntington’s disease, Alzheimer’s, and hereditary colorectal 
cancer.74-76   
However, these studies have not yet been applied to genetic testing for ASD. The 
framework (Figure 2) in this study is used to particularly test emotional and attitudinal 
factors that might determine the intention to undergo autism genetic testing among a 
sample of Taiwanese parents of children with ASD. 
Although the reported prevalence of ASD in Taiwan (12.3‰) was lower than the 
estimates from developed countries, a potential under-diagnosis and under-detection of 
ASD has made it an immediate public health concern.77,78 This phenomenon might be 
explained by the lack of recognition of ASD among clinicians, the lack acceptance of 
ASD in Taiwanese society, as well as the potential cultural influence in Taiwan.77 For 
instance, parents might feel ashamed or embarrassed by having a child with ASD, which 
can lead to the difficulty in acceptance of the diagnosis of ASD. A few epidemiologic 
studies focusing on enhancing the detection rate of ASD among the Taiwanese 
 35 
 
population are being conducted.78,79 However, until today, no recommended tests are 
available for patients and families with ASD in Taiwan. Since culture might have 
significant influence on Taiwanese people’s perspectives toward genomic disorders and 
disabilities (such as eugenics and social stigma of having a child with birth defects), it is 
critical to examine the decision-making process with regard to ASD genetic testing 
before the provision of this test.  
       
 
 
 
 
 
 
 
 
 
 
 
A better understanding of this decision-making process will provide information 
for (i) assisting genetic professionals to be aware of the existing psychological concerns 
among parents of children with ASD, (ii) establishing localized practice guidelines for 
health care providers to give appropriate referrals to ASD patients, and (iii) designing 
relevant educational interventions for parents of children with ASD prior to the offering 
Gender 
Age 
Education  
Income 
Anxiety 
Fear & Guilt 
guilt 
Attitudes  
Intention 
Figure 2. The integrative model of emotions, attitudes, and intention associated with 
undergoing autism genetic testing. 
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of the test. However, to date, little is known about factors regarding the intention to 
undergo autism genetic testing for parents of children with ASD in Taiwan.  
The goals of this study were to address the gaps in the literature on the decisions 
to undergo autism genetic testing. In this study, I used a multivariate analytic technique, 
SEM, to examine the theoretical framework for explaining parents’ emotional and 
attitudinal responses and their intention to undergo autism genetic testing. More 
specifically, this study explored the roles of (i) emotions, (ii) attitudes, and (iii) 
demographic variables in the decision-making process related to undergoing autism 
genetic testing among a sample of Taiwanese parents of children with ASD. The specific 
research questions and hypotheses were:  
1. Does the model adequately explain parents’ intention to undergo genetic 
testing for ASD? If this model is not adequate, what are the variables to be 
included in a refined model?  
H1a: The intent to undergo genetic testing for ASD can be positively 
predicted by parents’ anxiety pertaining to the test. 
H1b: The intent to undergo genetic testing for ASD can be negatively 
predicted by fear and guilt. 
H1c: The intent to undergo genetic testing for ASD can be positively 
influenced by positive attitudes toward the test. 
2. Will the model exhibit different patterns and values depending on 
participants’ demographic information (i.e., age, gender, education, income)? 
H2a: SEM models differ for parents with age≥ 35 years and < 35 years. 
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H2b: SEM models differ from mothers and fathers of children with ASD. 
H2c: SEM models exhibit different values for parents with high and low 
educational level. 
H2d: SEM models differ for parents with high annual household income and  
low annual household income.  
3. Which variables in the model can best predict parents’ intention to undergo 
autism genetic testing? Suppose both emotions and attitudes can predict 
intention, how much variability can be explained by parents’ emotions 
(including anxiety, fear, and guilt)? How much variability can be explained 
by parents’ attitudes toward testing? 
Theoretical Perspective 
Theoretical construction 
Based on the current literature on factors determining the attitudes, beliefs, and 
decision-making regarding genetic testing,31,50,73 I established an integrative model for 
this study (Figure 2). The key constructs included four latent variables (anxiety, fear & 
guilt, attitudes, intention) controlling for parents’ age, gender, income, and education. I 
also tested the four demographic factors (parents’ age, gender, education, and income) as 
moderators. The variables in this model are from the following validated theories: the 
Theory of Planned Behavior (TPB),47 Self-Regulation Theory (SRT),71 and the 
Transactional Model of Stress and Coping (TMSC).72  
The model was specifically designed to explain the emotional factors that 
facilitate or inhibit parents’ decisions to undergo autism genetic testing. The underlying 
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reason for constructing this combined model was as follows. Albeit preeminent health 
behavioral theories, such as the HBM and the TPB,46 have been widely employed in 
examining the decision-making processes related to genetic testing, they lack an 
important component in predicting the intention or the behavioral change: emotions.51,52 
Although less commonly used for genetic testing research, the two health 
psychology theories, SRT and the TMSC, have been employed to explain how people 
might exhibit emotional responses and cope with their emotional distress.51 In this study, 
I added emotional factors as influences on the intention regarding autism genetic testing 
among parents of children with ASD.  
The salient features of the model included the emphasis on emotional appraisal, 
coupled with attitudinal factors in assessing parents’ decision-making processes.51 This 
model highlighted the affect-type variables as important constructs to explain how 
people’s decisions regarding genetic testing/screenings might be shaped.  
Key constructs and demographic factors 
The key outcome variable in the model was parents’ behavioral intention to 
undergo genetic testing for ASD. Affect-type variables and attitudes were the predictor 
variables (Figure 2). It is hypothesized that in this model, parents’ intention regarding 
ASD genetic testing was correlated with their emotional responses and attitudes toward 
the test. Each of the three kinds of variables (i.e., affect-type variables, attitudes, and 
intention) interacts and connects with one another. The affect-type variables were 
composed of three subdomains: anxiety, fear, and guilt. Anxiety has three subgroups: 
trait anxiety, anxiety caused by ASD, and anxiety caused by ASD genetic testing. Based 
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on past literature,31,32,35 the parental attitudes are also further divided into three 
subdomains: (i) attitudes toward testing the immediate family of the affected child, (ii) 
attitudes toward carrier testing, prenatal diagnosis, and newborn screening, and (iii) 
attitudes toward testing individuals with a family history of ASD. Additionally, the 
overall moderating factors such as gender and age might influence these aforementioned 
factors. Below I will contextualize each of the variables employed in this model.  
Affect-type factors. Based on the preliminary findings from my previous work37 
on parents’ attitudes toward autism genetic testing and the reasons listed below, I 
specifically tested three emotional variables: fear, anxiety, and guilt. 
Fear. Fear is defined as “an unpleasant emotional state characterized by 
anticipation of pain or great distress and accompanied by heightened autonomic activity 
especially involving the nervous system.”80 Both SRT and the TMSC delineate fear as 
an important predictor in making decisions when people experience a specific health 
situation.51 Fear is among the most studied emotion in social science and can be a strong 
motivator for actions.81 As Protection Motivation Theory (PMT) theorizes, “fear may be 
considered a relational construct, aroused in response to a situation that is judged as 
dangerous and toward which protective action is taken.”82(p157) Evidence shows that 
stronger levels of fear can induce greater changes in attitudes, intention, and behaviors.83 
In this study, I tested the specific kind of fear related to negative consequences, privacy 
issues, genetic stigma, and discrimination caused by ASD genetic testing. Because the 
sample was from Taiwan, parents’ perspectives could possibly be influenced by 
traditional Chinese culture and societal pressure related to birth defects. From the 
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perspectives of traditional Chinese culture, children with “birth defect,” especially those 
with mental disorders, might be stigmatized and excluded from the mainstream society.77 
Anxiety. Anxiety refers to “an emotion characterized by feelings of tension, 
worried thoughts, and physical changes like increased blood pressure. People with 
anxiety disorders usually have recurring intrusive thoughts or concerns. They may avoid 
certain situations out of worry.”84 Although anxiety is not specifically described as an 
affect-type variable in the constructs of SRT and the TMSC, previous literature has 
extensively described anxiety as one of the most common emotional responses related to 
genetic testing.2,5Anxiety has two related types: state anxiety and trait anxiety. The 
former one is a transitory emotional reaction that includes a subjective feeling of 
nervousness and worry.85 However, trait anxiety refers to “an enduring characteristic of 
a person that can be used to explain a person’s behavioral consistencies, and determines 
the likelihood a person will experience anxiety in stressful situations.”86 Previous studies 
have demonstrated that both state anxiety and trait anxiety were related to undergoing 
genetic testing for hereditary breast, ovarian, and colon cancers.5 In this study, both trait 
anxiety and state anxiety were evaluated. 
Guilt. Guilt is a “cognitive or an emotional experience that occurs when a person 
realizes or believes—accurately or not—that he or she has compromised his or her own 
standards of conduct or has violated a moral standard and bears significant responsibility 
for that violation.”87 Compared with anxiety and fear, the feeling of guilt is not well 
researched in genetic testing research. However, guilt is a prevalent emotional response 
to hereditary diseases across a wide range of genetic conditions.88 In the context of 
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genetic screenings, guilt can be caused by feeling the passing of a faulty gene to 
children, causing them to have certain genetic diseases or the higher risk for developing 
the disease. A previous study indicates that the emotional responses to genetic conditions 
are often characterized by feelings of guilt.88 Since genetic testing is meant to detect 
certain diseases running in the family, it is very likely to provoke the feeling of guilt 
among family members and affect their individual intention of undergoing genetic 
testing. I assessed guilt associated with having children with ASD and undergoing 
genetic testing for ASD in this study. 
Attitudes. According to Eagly and Chaiken,89 attitude is defined as the 
subjective evaluation of an object or action and it can be positive or negative. Attitude is 
a major determinant elucidated in TPB associated with people’s engagement in a 
specific behavior.47 Prior studies that explored the domains of TPB show individuals’ 
positive attitudes are correlated with their intention to be tested for colorectal, 
breast/ovarian cancer, and Alzheimer’s disease.4,46,90 Two dimensions of attitudes can be 
measured: values and beliefs.91 This study assessed both dimensions.  
Intention. As depicted in the TPB, behavior is directly driven by people’s 
intention. The TPB has been substantially used to predict and explain human behavior in 
diverse health-related contexts including genetic testing intention.46 Similar to the TPB, 
the model of interpersonal behavior (MIP) also emphasizes the main construct of 
“intention” as the antecedent of individuals’ behaviors.81 The intention to be tested in 
this study was the intention of undergoing genetic testing for (i) children with ASD, (ii) 
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siblings of children with ASD, (iii) parents of children with ASD themselves, (iv) their 
spouses, (v) relatives from their biological family, and (vi) relatives of their spouses. 
Demographic factors. As the HBM and TMSC theorize, a variety of socio-
demographic factors (such as age, education, income, and ethnicity) might influence 
people’s intention to undergo genetic screening. For instance, interest in and uptake of 
genetic testing for hereditary cancer has been related to education level, income, and 
better health insurance coverage.51 In this study, age, gender, educational level, and 
annual household income were measured as moderating factors.  
Methodology and Study Design 
This study is a secondary data analysis of a larger research project initiated by 
Dr. Lei-Shih Chen in the Department of Health and Kinesiology at Texas A&M 
University and co-directed by Dr. Tse-yang Huang in the Department of Special 
Education, National Hsinchu University of Education, Taiwan. The research project, 
funded by the Chiang Ching-kuo Foundation for International Scholarly Exchange, was 
conducted with parents of autistic children in Taiwan.  
Based on previous literature,91-94 the research team developed a paper-and-pencil 
survey to investigate factors affecting the intention of undergoing genetic testing among 
the study population. This multi-part survey was designed to measure domains, 
including: (i) demographic information regarding the parents, the ASD-affected children, 
and the participants’ knowledge of ASD genetic testing, (ii) parents and the families’ 
previous experience with genetic services, (iii) affect-type factors that might influence 
parents’ decisions to undergo genetic testing, (iv) parents’ perceived benefits in 
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undertaking genetic testing, (v) parents’ perceived barriers in undertaking genetic 
testing, (vi) perceived behavioral control, (vii) social support, (viii) parents’ attitudes 
toward ASD genetic testing, and (ix) intention to undergo ASD genetic testing. The 
questionnaire was developed in traditional Chinese (the official language in Taiwan) for 
the convenience of the participants.  
Once drafted, the preliminary survey was sent to two MDs (one family doctor 
and one genetic pediatrician), one special education expert, and one social behavioral 
specialist for assessing content validity of the items. After the revision based on the 
experts’ suggestions, the survey was pilot tested in Taiwan. The research team invited 
seven parents of children with ASD to participate in the cognitive interview, four parents 
to participate in the retrospective interview, and one parent to participate in both 
cognitive and retrospective interviews. The questionnaire was then pilot tested with four 
parents.  
Sample and Recruitment 
The sampling and recruitment were carried out with the assistance of the 
Department of Special Education, National Hsinchu University of Education, Taiwan, 
which represented an extensive network of all the teachers and parents of special 
education classes in the Hsuichu area. Initially, the research team retrieved the list of all 
preschools and elementary schools with special education classes in the Hsinchu area 
and Taoyuan County from the official website of the Department of Education. Then, 
phone calls were made to the special education/resource teachers working in the 
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abovementioned schools to obtain the exact number of children with ASD in their 
schools.  
Afterwards, parents of all the children with ASD enrolled in these schools were 
directly contacted by their special education/resource teachers and invited to participate 
in this study. Subsequently, a package containing the survey and information sheet was 
distributed to all the potential participants in the Hsuichu area and Taoyuan County by 
the teachers. In order to enlarge the sample size, the research team extended this study to 
Miaoli County and other areas in Taiwan. All participating parents were encouraged to 
complete the survey and return it to their children’s teachers in two or three weeks to 
meet the deadline for entering the drawing. Each participant had the opportunity to 
enroll in the drawing and win gift vouchers for their participation. The first-place prize 
was for eight participants and each of them won a gift voucher of NT$ 3,000 ($100). The 
second-place prize was for 20 participants and the gift voucher was NT$ 2,000 ($67). 
Lastly, the third-place prize was for 200 participants and each winner received a gift 
voucher of NT$ 1,000 ($33).  
Altogether 243 schools responded to the study, 862 surveys were sent to 
participants, and 454 were returned (response rate: 52.8%). Although the approval of an 
Institutional Review Board (IRB) is not mandatory in Taiwan, all research protocols for 
this study were approved by the IRB at Texas A&M University.  
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Measures 
As illustrated in Figure 2, the conceptual model that was tested included two 
types of categories: (i) predicator variables and (ii) the outcome variable. The measures 
used in this model are summarized below. 
Outcome variable: Parents’ intention to undergo autism genetic testing 
Six items were used in measuring parents’ intention to take the test. Parents were 
asked to respond to the question asking the intention of testing the following people: (i) 
their children with ASD, (ii) the siblings of their children with ASD, (iii) themselves, 
(iv) their spouses, (v) relatives from their biological family, and (vi) relatives of their 
spouses. Possible responses were “very unlikely,” “unlikely,” “likely,” “very likely,” 
“children had been tested before [for participating research],” and “children had been 
tested before [not for participating research].” Responses were reported on a four-point 
scale ranging from “very unlikely,” “unlikely,” “likely,” and “very likely.”  
Predicator variables: Affect-type variables and attitudes toward undergoing ASD 
genetic testing 
First, affect-type variables included three subdomains of measurements: anxiety, 
fear, and guilt. Anxiety was composed of two elements that consisted of both trait 
anxiety and state anxiety. Trait anxiety was evaluated by six items. These six items 
assessed participants’ enduring characteristics related to anxiety. State anxiety is the 
anxiety that lasts for a short period of time and it was evaluated by (i) six items related to 
the anxiety caused by the disease of ASD, (Anxiety-ASD) and (ii) five items associated 
with the anxiety caused by ASD genetic testing (Anxiety-GT). Parents were asked to 
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respond a four-point response format, from strongly agree to strongly disagree (e.g., 
“Thinking about ASD makes you feel worried” and “Thinking about the possible 
problems caused by ASD genetic testing, for instance, family disputes from knowing 
who has the ASD-associated genes and future marriage problems for children with ASD, 
makes you feel anxious.”) 
The five-items for fear assessed parents’ perceptions about the possible 
consequences or social, legal concerns related to undergoing autism genetic testing. 
These items were as follows: “You are fearful of the negative consequences caused by 
ASD genetic testing (e.g., family disputes from knowing who has the ASD-associated 
genes and future marriage problems for children with ASD),” “You are fearful of the 
violation of your privacy caused by the ASD genetic testing (e.g., others might know my 
test results),” “You are fearful of genetic discrimination caused by ASD genetic testing,” 
“You are fearful of stigmatization caused by ASD genetic testing,” and “You are fearful 
that the general public will not accept individuals with ASD.” All the responses in this 
section were divided into four categories: “Strongly disagree,” “Disagree,” “Agree,” and 
“Strongly agree.” 
Guilt was assessed by nine items, for instance, “You feel guilty toward your 
child, because you brought this child to the world.” “You feel guilty toward your child, 
because he or she has ASD, but you are healthy” “You feel guilty toward your child with 
ASD, because the biological father/mother or yourself might carry ASD-associated 
genes, which causes your child’s ASD” and “Taking your child with ASD to undergo 
ASD genetic testing makes you feel guilty.” Similar to the assessment with other affect-
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type variables, all the responses in this section were also divided into four categories: 
“Strongly disagree,” “Disagree,” “Agree,” and “Strongly agree.” 
Second, parents’ attitudes toward genetic testing in children were composed of 
three subdomains: (i) Attitudes toward testing the immediate family, (ii) Attitudes 
toward carrier, prenatal, pre-implantation genetic diagnosis (PGT), and newborn 
screening for ASD, and (iii) Attitudes toward testing individuals with family history of 
ASD. Respondents were asked to indicate their personal beliefs and values in this 
construct. Items loading on each respective domain were summed to constitute both the 
belief and the value measures of attitudes. All the responses in this section were also 
divided into four categories: “Strongly disagree,” “Disagree,” “Agree,” and “Strongly 
agree.” 
Data Analysis 
Descriptive analyses and exploratory analyses  
Before testing the hypothesized model presented in Figure 2, I conducted 
descriptive and exploratory analyses with the assistance of IBM SPSS version 22. For 
the variables (both predictor and outcome variables), the psychometric properties were 
calculated for examining the tendency in the data. Statistical significance of hypothesis 
testing is reported at the level of 0.05. Whenever possible, the actual p-values were 
provided.95 
The two-step SEM modeling 
After performing the descriptive as well as exploratory analyses, I used a two-
step Structural Equation Modeling (SEM) analysis to evaluate whether the data 
 48 
 
substantiated the hypothesized model (Figure 2). The reasons for choosing SEM data 
analysis are as follows: (i) SEM is a multivariate analytical technique designed to test 
theoretical models,96 and (ii) SEM can capture the complexity of the social science 
phenomena more accurately. Testing the theoretical constructs can make contributions to 
advancement in the field of health behavioral research as theory-based programs are 
needed. In the model, SEM allows for testing and clarifying the dynamic relationship 
and interactions among multiple constructs, i.e., affect-type variables (anxiety, fear & 
guilt), attitudes, and intention. (iii) SEM is advantageous in controlling for the inflation 
of experimental (Type I) error, which potentially reduces the chance of falsely rejecting 
the null hypothesis.96 (iv) Unlike path models that only involve observed variables, SEM 
is compatible for both observed and latent variables; thus, it can simultaneously test the 
measurement hypotheses (i.e., whether observed variables are good indicators of 
underlying factors) and structure relations (i.e., whether there are direct or indirect causal 
effects among latent factors) in a single model.97,98  
Sample size needs to be considered adequately in estimating and interpreting the 
results of SEM. As indicated by Hair and colleagues,99 the estimated number for a 
critical sample size that would meet with the requirement for maximum likelihood 
estimation is 200, with above 500 being “too sensitive” because it might detect too many 
differences.100,101 The bare minimum for each estimated construct is 10 observations. In 
the hypothesized model, I needed to present a minimum of 190 observations. This study 
incorporated the responses from 444 parents of children, which is “sufficient to detect 
model fit without becoming ‘too sensitive.’”101(p52)  
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The model was assessed with a powerful software package Mplus 7.11 due to its 
flexibility for handling different data structures and offering FIML (full information 
maximum likelihood) to deal with missing data. Mplus provides several indexes to 
diagnose the goodness-of-fit in the structural model, including chi-square, Comparative 
Fit Index (CFI), the Root Mean Square Root Error of Approximation (RMSEA), and 
Standardized Root Mean Square Residual (SRMR).102 Chi-square statistic was not 
considered a primary index for evaluating the model fit due to a few widely 
acknowledged limitations, such as a high sensitivity to the sample size.96 Both CFI and 
RMSEA have been proven to increase the likelihood of maintaining true-population 
models and to reduce the chance of rejecting fit models.101 The cutoff values for these fit 
indexes were not consistently recommended.97 However, based on previous literature, I 
used the following cutoff criteria-values of RMSEA less than .06, SRMR less than .05, 
and CFI more than .90.102,103 
The initial SEM step comprised of a confirmatory factor analysis (CFA) which 
established a measurement model as well as determined latent model constructs.49 Nine 
latent model constructs were evaluated through conducting CFA, i.e., trait anxiety by six 
items, state anxiety caused by ASD by six items, state anxiety caused by ASD genetic 
testing by five items, fear by five items, guilt caused by carrying ASD genes by three 
items, guilt caused by undergoing ASD genetic testing by six items, attitude toward 
testing the immediate family members by five items, attitudes toward carrier, prenatal, 
PGD, and newborn screening by six items, and intention by six items. The use of a latent 
variable “allows for the assessment of the measurement error associated with each 
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construct and the measurement model analysis provides a number of diagnostics to 
evaluate the validity of the constructs.”49(p435) I utilized Mplus MLR estimator as the 
statistical measurement tool. This estimator served several functions: (i) computed 
standard errors, (ii) allowed for FIML handling as well as producing maximum 
likelihood estimations, and (iii) provided diagnosis for model modifications.49,98  
After establishing an adequate fit for the measurement model, I started to use the 
structural model to assess the underlying relationship between and among the variables 
[anxiety→ intention, fear & guilt → intention, attitude → intention]. To determine if the 
hypothesized model fit the observed data, I examined the following goodness-of-fit 
indexes: the chi-square, RMSEA, SRMR, based on the cutoff criteria-values of RMSEA 
less than .06, SRMR less than .05, and CFI more than .90. 
Model modification method 
Modifications of the model were then made by removing insignificant paths to 
make the model fit more sufficiently, after defining the final model, I tested the 
hypotheses by evaluating the reduced models. The researcher tested the hypotheses 
either by “evaluating the significance and magnitude of path coefficients or by model 
comparisons using fit statistics.”104(p1252) 
Both theoretical and statistical criteria were used to evaluate the simplification of 
the full model in Figure 2 into a reduced, more parsimoniously alternative model.101 To 
eliminate a variable or a latent construct, one needs to consider theoretical merits as well 
as statistical properties simultaneously.101,104  
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Results 
Participants 
The final sample consisted of 444 parents of children with ASD in Taiwan and 
represented a total response rate of 52.3%. Participants were predominately females 
(77.5%) with an average age of 39.9 years (SD=5.4, range= 28-63). The average age of 
their spouses was 41.3 years (SD=5.6, range=26-63). This study involved 468 children 
diagnosed with ASD (88% were boys). The average age of these children with ASD was 
9.5 ± 2.24. Most of the respondents (95.2%) claimed they were born in Taiwan, the 
remaining (4.8%) were from other countries, for instance, Mainland China, Burma, 
Indonesia, and Thailand. Participants’ educational levels were diverse: most had not 
completed college (67.3%), and 32.7% had a college degree or postgraduate degrees. 
The majority of respondents were married (88.7%) and the others were either divorced 
or single.  
Slightly more than half (50.2%) of the participants claimed they did not have 
full-time jobs (for example, were unemployed, had part-time jobs, or were retired). The 
remaining (49.8%) reported they had full-time jobs. Altogether, 33.6% of the parents 
reported making the equivalent of less than $20,000 annual household family income; 
40.8% fell between $20,000 and $40,000, 14.6% reported incomes between $40,000 and 
$60,000, 5.6% fell between $60,000 and $80,000, 2.3% reported incomes over $80,000, 
and 13 participants (3.1%) refused to report their income. 
In terms of their religious beliefs, 25.9% espoused Buddhism, Folk Religion 
(27.5%), and Christianity (9%). About 21.2% participants claimed to be Atheists or 
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Non-Believers, and 14.8% reported other religious beliefs. Table 2 summarizes the 
details of the demographic information of the 444 participants.  
Along with having at least one child diagnosed with ASD, 8.1% of parents 
reported their family members (including themselves) had also been diagnosed with 
ASD, and 16.3% of parents reported their family members (including themselves) had 
ASD symptoms or traits of ASD. Similarly, 10.6% of parents reported their spouses’ 
family members (including their spouses) had the diagnosis of ASD and 21.3% parents 
reported their spouses’ family members (including their spouses) had ASD symptoms or 
traits.  
Preliminary analyses 
I first examined the data for missing values and patterns. The amount of missing 
data ranged from 2% to 7.6%. I used the most widely used technique for estimating 
SEM, full information maximum likelihood (FIML), to deal with the missing data. 
Under the assumption of multivariate normality, FIML produces parameter estimates 
that “perform optimally over ad hoc methods such as deletion or meansubstitution.”98(p68)  
Following the procedure,105 I imputed -99 to replace the missing values in the dataset.  
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Table 2 Study sample characteristics (N=444) 
Note. The sample size (N=444) was used for the preliminary stage of the data analysis. 
 
 
Based on Mardia’s measure of relative multivariate kurtosis (MK),95 I tested the 
normality of the variables and moderators (emotional factors, attitudes, and intention, as 
well as age, gender, education and income). I calculated the psychometric properties for 
emotions, attitudes, and intention (see Table 3 for details). The skewness and kurtosis 
Characteristics n (%) 
Gender   
    Female  334 (77.5) 
    Male  97 (22.5) 
Age of parents, mean ± SD (range) 39 ± 5.4 (28-63) 
Age of spouses, mean ± SD (range) 41.3 ± 5.6 (26-63) 
Birth place  
  Taiwan 413 (95.2) 
  Non-Taiwan 21(4.8) 
Education  
   Below college  292 (67.3) 
   Above college  141 (32.7) 
Marital status  
   Married 384 (88.7) 
   Others (divorced, single ) 50 (11.3) 
Current Employment Status  
   Non-full time 218 (50.2) 
   Full time 216 (49.8) 
Annual household income  
    <TW$ 600K (~US$20K) 143 (33.6) 
   TW$ 600K (~US$20K) to < TW$1200K (~US$40K) 174 (40.8) 
   TW$1200K (~US$40K) to < TW$1800K (~US$60K) 62 (14.6) 
   TW$1800K (~US$60K) to < TW$ 2400K (~US$80K)  24 (5.6) 
   ≥TW$ 2400K (~US$80K) 10 (2.3) 
  Others  13 (3.1) 
Religion  
   Buddhism 112 (25.9) 
   Folk religions 119 (27.5) 
   Atheists or Non-believers 
   Others  
92 (21.2) 
64 (14.8) 
   Christian (catholic) 39 (9) 
   I-kuan Tao  7 (1.6) 
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coefficients ranged from +1 to -1. The results indicated that the data did not violate the 
normality assumption.95 
 
Table 3 Psychometric properties of all psychological variables 
Variable 
 
No. 
items 
Response  
Range M SD Skewness Kurtosis 
Emotions       
Trait anxiety 6 1-4 2.474 .538 -.019 .610 
ASD anxiety 6 1-4 2.562 .617 .125 .287 
ASD-GT anxiety 5 1-4 2.344 .619 .337 .717 
Fear 5 1-4 2.641 .603 -.032 .228 
Guilt 9 1-4 2.284 .496 .063 .712 
Attitude  
     
Attitude A 5 1-16 7.873 3.458 .719 .347 
Attitude B 6 1-16 6.076 2.995 .900 .898 
Attitude C 3 1-16 9.244 3.564 .308 -.498 
Intention  6 1-6 2.499 .662 .128 .528 
 
 
 
Anxiety was primarily assessed by three subscales: trait anxiety (6 items), state 
anxiety caused by ASD (6 items), and state anxiety caused by ASD-GT (5 items). 
Higher scores indicated a higher level of anxiety. The composite mean score for trait 
anxiety was 2.48 (SD=.54), ASD anxiety 2.56 (SD=.62), and ASD-GT anxiety 2.34 
(SD=.62). The anxiety statements with which most parents agreed were: “Thinking of 
ASD makes you feel worried” (75.8%; ASD anxiety), “You easily get worried” (61.8%, 
trait anxiety), and “Thinking about the possible problems caused by ASD genetic testing 
makes you feel stressed and worried during the past year” (50.3%, ASD-GT anxiety).  
Fear & guilt was reflected by one fear scale (5 items) and two guilt scales (guilt 1 
with three items, guilt 2 with 6 items). The composite mean score for fear was 2.64 
(SD=.60) and for guilt was 2.28 (SD=.50). The fear statements with which most 
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participants agreed were: “You are fearful that the general public in Taiwan will not 
accept individuals with ASD” (70.4%). The guilt statements with which most 
participants agreed were: “You feel guilty toward your child with ASD, because you 
brought this child to the world” (65.1%). All the statements assessing emotional factors 
and the percentages of the agreement with these statements are listed in Table 4.  
Attitudinal factors were examined with three subscales containing 14 items 
assessing respondents’ beliefs and another 14 items capturing respondents’ values. Table 
5 depicts the frequency of agreement with each of the items. I first asked the respondents 
about their beliefs regarding undergoing genetic testing for ASD; subsequently, I asked 
about their values (how important they considered the testing to be). The belief 
statements with which the majority of the parents agreed was: “ASD genetic testing 
should be mandatory for newborn screenings” (84.8%), whereas the statement with the 
least amount of agreement was “All the relatives of children with ASD should undergo 
ASD genetic testing” (22.2%). Similar to these percentages, was the pattern of responses 
to the items assessing values. I used combined scores on the belief and value items for 
analyzing respondents’ attitudes. The composite mean score for Attitude A was 7.83 
(SD=3.45), Attitude B was 6.07 (SD=2.99), and Attitude C was 9.24 (SD=5.56). Each of 
these items and their percentage distributions are shown in Table 5. 
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Table 4 Emotional factors (trait anxiety, state anxiety caused by ASD, state anxiety caused by 
ASD genetic testing, fear, and guilt) and the percentages of the individual statement  
 
  Strongly 
Disagree   
(%) 
Somewhat 
disagree 
(%) 
Somewhat  
Agree 
(%) 
Strongly 
Agree 
(%) 
     
Trait anxiety  
 
    
You easily get worried 5.1 33.1 54.3 9.7 
You are easily inclined to feel anxious (e.g., do not sleep 
well, irregular diet, irritable, etc.) 
6.7 40.4 42.3 10.6 
You tend to be pessimistic 11.5 61.2 24.5 3.8 
You easily get worried 5.1 33.1 54.2 7.6 
You cannot handle emergencies calmly 9.1 61.9 25.2 3.7 
You felt nervous or worried during the past year 8.9 42.1 40.0 8.9 
 
State anxiety caused by ASD 
 
    
Thinking of ASD makes you feel nervous  5.3 40.6 43.5 10.6 
ASD causes you to feel anxious (e.g. do not sleep well, 
irregular diet, irritable, etc.) 
6.5 45.9 38.0 9.7 
ASD makes you feel pessimistic about life 7.4 51.4 33.9 7.4 
Thinking about ASD makes you feel worried  3.7 20.5 63.2 12.6 
Thinking about ASD can make you feel uneasy  6.2 52.7 34.2 6.9 
Thinking about ASD made you feel stressed and worried 
during the past year 
5.8 39.4 46.1 8.8 
 
State anxiety caused by ASD genetic testing  
 
    
Suppose ASD genetic testing is available in the hospitals 
of Taiwan. Thinking about the possible problems caused 
by ASD genetic testing 
  makes you easily feel nervous 7.2 49.7 38.1 5.1 
  makes you feel anxious  7.2 57.4 30.1 5.3 
  makes you feel pessimistic about life  9.0 63.8 22.3 4.9 
  makes you feel stressed and worried during the past 
  year 
 
6.7 42.9 44.3 6.0 
  makes you feel uneasy in your daily life 7.9 63.4 25.2 3.5 
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Table 4 Continued 
  Strongly 
Disagree 
(%) 
Somewhat 
disagree 
(%) 
Somewhat  
Agree 
(%) 
Strongly 
Agree 
(%) 
 
Fear 
 
 
6.9 
 
 
44.0 
 
 
41.5 
 
 
7.6 
 You are fearful of the negative consequences caused 
by ASD genetic testing (e.g., family disputes from 
knowing who has the ASD-associated genes and future 
marriage problems for children with ASD) 
You are fearful of the violation of your privacy caused 
by the ASD genetic testing (e.g., others might know 
my test results) 
4.1 42.4 45.6 8.0 
You are fearful of genetic discrimination caused by 
ASD genetic testing 
3.7 40.9 45.3 10.2 
You are fearful of stigmatization caused by ASD 
genetic testing 
3.7 34.3 50.8 11.2 
You are fearful that the general public in Taiwan will 
not accept individuals with ASD 
2.8 26.8 54.8 15.6 
  
 
 
6.2 
 
 
 
28.8 
 
 
 
51.6 
 
 
 
13.5 
Guilt  
 You feel guilty toward your child with ASD, because 
you brought this child to the world 
You feel guilty toward your child with ASD, because 
he or she has ASD, but you are healthy 
8.7 37.0 44.7 9.6 
You feel guilty toward your child with ASD, because 
the biological father/mother or yourself might carry 
ASD-associated genes, which causes your child’s ASD 
9.8 47.1 35.7 7.3 
Taking your child with ASD to undergo ASD genetic 
testing makes you feel guilty 
11.7 68.3 18.6 1.4 
Taking the siblings of your child with ASD to undergo 
ASD genetic testing makes you feel guilty 
11.1 66.8 20.0 2.1 
Taking the biological father of your child with ASD to 
undergo ASD genetic testing can make you feel guilty 
11.3 66.9 18.6 3.2 
If you undergo ASD genetic testing, you feel guilty 13.8 69.3 15.6 1.4 
Taking your biological family members to undergo 
ASD genetic testing makes you feel guilty 
Taking the biological family members of the biological 
father of your child with ASD to undergo ASD genetic 
testing makes you feel guilty 
 
10.8 
 
10.7 
60.8 
 
58.3 
25.2 
 
26.6 
3.2 
 
4.4 
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Table 5 Percentage distribution of the attitudes toward ASD genetic testing among parents of 
children with ASD 
                                                                                                                                       
                                                                                                            Attitudes toward ASD genetic testing 
 
 
Statements regarding parents’ attitudes 
toward ASD genetic testing  
Beliefs (%) Values (%) 
Disagree  Agree  Not very 
Important  
 Important 
 
 
Attitude A: testing the immediate family 
 
All children diagnosed with ASD 
should undergo genetic testing. 
 
 
33.1% 
 
 
 
 
 
66.9% 
 
 
 
 
 
29.9% 
 
 
 
 
 
 
70.1% 
 
 
 
All children with characteristics or 
traits with ASD should undergo genetic 
testing. 
35.5%  64.5%  31.2%  68.8%  
All the siblings of child with ASD 
should undergo ASD genetic testing. 
48.4%  51.6%  41.5%  57.5%  
All the biological mothers of child with 
ASD should undergo ASD genetic 
testing. 
39.4%  60.6%  37.5%  62.5%  
All the biological fathers of child with 
ASD should undergo ASD genetic 
testing. 
39%  60.9%  37.5%  62.5%  
 
Attitude B: carrier, prenatal, pre-
implantation genetic diagnosis 
(PGT),and newborn screening 
 
All the mothers of children with ASD 
should undergo ASD genetic testing 
during next pregnancy. 
 
 
 
 
 
23.7% 
 
 
 
 
 
 
 
 
 
 
 
 
76.3% 
 
 
 
 
 
 
 
 
 
 
21.7% 
 
 
 
 
 
 
 
 
 
 
78.3% 
 
 
 
 
 
All the newborns of the parents of 
children with ASD should undergo 
genetic testing. 
29.8%  70.2%  27.8%  72.2%  
ASD genetic testing should be included 
in pre-marital heath examination. 
29.8%  70.2%  29.0%  71%  
All pregnant women should undergo 
ASD genetic testing during prenatal 
testing. 
28.8%  71.2%  28.5%  71.5%  
ASD genetic testing should be part of 
pre-implantation genetic diagnosis.  
27%  73%  26.1%  73.9%  
ASD genetic testing should be 
mandatory for newborns screenings. 
 
15.2%  84.8%  15.9%  84.1%  
Attitude C: testing individuals with 
family history of ASD 
 
        
All the relatives of the child with ASD 
should undergo ASD genetic testing. 
77.8%  22.2%  73%  27%  
An individual with at least one 
immediate family member of ASD 
(parents, siblings, or children) should 
undergo ASD genetic testing.  
65%  35%  40.4%  59.6%  
An individual with at least one family 
member of ASD (grandparents, uncles, 
aunts, cousins) should undergo genetic 
testing. 
  
62.8%  37.2%  61.3%  38.7%  
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Intention was measured by six items assessing parents’ likelihood to test with a 
possible score of 6. For this scale, great intention to undergo the test was indicated by 
higher scores. As indicated in Table 6, the mean score for each of the intention items 
was 3.15 (SD=0.83), 2.73 (SD=0.94), 2.86 (SD=0.92), 2.58 (SD=0.99), 1.92 (SD=.072), 
and 1.79 (SD=0.68) respectively. Overall, parents indicated that they would be “likely” 
or “ very likely” to “bring your child with ASD to undergo ASD genetic test” (86.8%), 
“undergo the testing yourself” (68.5%), and “take your children without ASD (siblings 
of child with ASD) to undergo ASD genetic testing” (62.4%). Fewer parents indicated 
that they would bring “the relatives of your spouse to undergo genetic testing” (13.3%). 
The actual statements used in this survey and the frequency counts are reflected in Table 
6. 
 
Table 6 Percentage distributions of the likelihood of undergoing ASD genetic testing 
                                           Likelihood of Undergoing ASD genetic testing (%) 
Individuals involved… Likely  Unlikely   
Your child with ASD  86.8%  13.2%   
Your child without ASD  
(siblings of your child with ASD) 
  
62.4%  37.6%   
Yourself 68.5%  31.5%   
Your spouse 52.5%  47.5%   
Relatives from your biological family 
 
18.4%  81.6%   
Relatives of your spouse 13.3%  86.7%   
Note. The answer options ‘likely’ and ‘very likely’ were combined into one category as were the options ‘unlikely’  
and ‘very unlikely.’  
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Confirmatory factor analysis 
Correlation and reliability. Table 7 demonstrates the correlation matrix for 
these items related to emotions, attitude, and intention as well as participants’ 
demographic information. The individual items comprising emotional and attitudinal 
factors primarily correlated among themselves. For instance, the highest correlation was 
found between the items for Attitude A and Attitude B (r = 0.679, p<0.01). ASD anxiety 
and trait anxiety (r = 0.623, p<0.01) were highly correlated also. In addition, the 
correlations between fear & guilt were significant (r=0.442, p<0.01), albeit not as high. 
These results provided evidence for hypothesized latent constructs in this study. 
Construct validity. Because the model involved four latent variables, it was 
important to first establish measurement adequacy before testing the structural 
relationships in Figure 2. I conducted a series of confirmatory factor analyses (CFAs) to 
evaluate the factorial validity of the measurement scales used in this study. All factor 
loadings were significant at the .01level. Detailed information is demonstrated in Table 
8. 
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Table 7 Correlation matrix for individual items related to the composite scores for gender, age, income, education, trait anxiety, ASD 
anxiety, GT anxiety, fear, guilt, Attitude A, Attitude B, and Attitude C, and intention 
 
 Indicator  Gender  Age  Income Education  Trait 
anxiety  
ASD 
Anxiety  
GT 
Anxiety 
Fear Guilt  Attitude 
 A 
Attitude  
B 
Attitude 
C 
Intention 
              
Gender              
Age .328**             
Income .026 .200**            
Education .039 .153** .443**           
Trait anxiety a -.188** -.099* -.067 -.068          
ASD Anxiety b -.089 .030 .009 .004 .623**         
GT Anxiety C -.106* -.102* -.145** -.223** .458** .567**        
Fear -.075 -.053 -.082 -.120* .265** .343** .585**       
Guilt .017 -.008 -.121* -.181** .296** .363** .441** .442**      
Attitude A d -.032 -.129* -.119* -.164** .144** .129* .095 .031 -.039     
Attitude B e -.072 -.146** -.038 -.101 .080 .070 .086 -.007 -.076 .679**    
Attitude Cf -.059 -.121* -.054 -.120* .095 .137** .103* .066 .035 .667** .649**   
Intentions -.001 -.094 .074 .040 .132** .080 .065 -.092 -.057 .458** .429** .349** .456** 
Note. ** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 level (2-tailed) ;a Anxiety related to the anxiety level as a personal characteristic;  
b Anxiety caused by Autism Spectrum Disorders; c Anxiety caused by genetic testing for ASD;d Attitudes toward testing the affected child and family members;  
e Attitudes toward carrier testing, parental diagnosis and newborn testing; f Attitudes toward testing individuals with family history of ASD;  
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Table 8 Range of the standardized factor loadings, indicator reliability, and N of items 
for the Confirmatory Factor Analysis (CFA) model 
Indicator Standardized  Indicator  N of Items  
 Factor Loading Reliability (R2)  
    
Trait anxiety  .582-.754 .850 6 
ASD anxiety  .762-.850 .922 6 
GT anxiety  .853-.929 .946 5 
Fear .648-.905 .895 5 
Guilt1 .596-.924 .884 3 
Guilt 2 .776-.874 .862 6 
Attitude A .862-.900 .946 5 
Attitude B .773-.853 .906 6 
Attitude C .580-.899 .824 3 
Intention .736-.912 .894 4 
 
 
The results showed that, as I hypothesized, the measurement items testing trait 
anxiety loaded on one factor (range of factor loading: 0.582-0.754; 6 items), ASD-
related anxiety loaded on one factor (range of factor loading: 0.762-0.850; 6 items) and 
GT-anxiety caused by ASD genetic testing also loaded on one factor (range of factor 
loading: 0.853-0.929, 5 items). Similarly, all five items regarding fear were loaded on 
one factor (range of factor loading=0.648-0.905). In addition, among the nine items for 
“guilt,” the first three items–Guilt 1 loaded as one factor (range of factor loading: 0.596-
0.924, three items), and the six remaining items–Guilt 2 loaded as a second factor (range 
of factor loading=0.776-0.874). The three items for Guilt 1 refer to the feeling of guilt 
brought by passing the ASD-associated genes to the family members; the remainders 
represented Guilt 2, which mainly discussed the feeling of guilt about taking the 
immediate and extended families to undergo autism genetic testing.  
 63 
Factor loading also supported the hypotheses in dividing the “attitude” items into 
three categories. These three categories included Attitude A: Attitudes toward testing the 
immediate family members (range of factor loading=0.862-0.900; 5 items); Attitude B: 
Attitudes toward carrier, prenatal, PGD, and newborn screening (range of factor loading: 
0.773-0.853, 6 items); and Attitude C: Attitudes toward testing individuals with family 
history of ASD (range of factor loading: 0.580-0.899, 3 items). 
 Although all these scales were adopted from previous literature, the initial CFAs 
of the intention scale (item1-6) showed two items that form intention did not load on the 
latent construct at an acceptable level (i.e., with loading below 0.45). Based on this 
finding and a recently published psychometric analysis, I removed these two items from 
the scale. The range of the factor loading for the remaining four items was 0.736-0.912. 
A subsequent CFA containing all four constructs showed that the latent construct 
“anxiety,” “fear & guilt,” “attitudes,” and “intention” and their observed measures were 
well supported. The resulting CFA fit statistics included a chi-square =2803.9, df =1112, 
p<.001, CFI=0.92, RMSEA=0.04, 90% confidence interval (CI) for RMSEA [0.043 
0.049]), SRMR: 0.06. All fit indexes fell within acceptable ranges and all the factor 
loadings are significant (> 0.7). 
Table 7 also shows the internal consistency of these observed items using 
Cronbach’s alpha coefficient. All the indexes reached above the acceptance level. These 
indexes supported the use of these items to measure anxiety, fear & guilt, attitudes, and 
intention in this dataset. The Cronbach’s alpha was as follows: trait anxiety (.85), ASD 
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anxiety (.92), GT anxiety (.95), fear (.90), guilt 1 (.88), and guilt 2 (.86), Attitude A 
(.95), Attitude B (.91), Attitude C (.82), and intention item 1-4 (.89).  
Structural model 
After confirming that the measurement model exhibited appropriate fit, I 
performed SEM to verify the structural relationships in this study.49 I replaced the latent 
correlations in the measurement model. The hypothesized relationships were indicated in 
Figure 3.  
Research question 1. Does the model adequately explain parents’ intention to 
undergo autism genetic testing? If this model is not adequate, what are the variables to 
be included in the refined model?  
The integrative model in this study contained four latent variables, i.e., anxiety, 
fear & guilt, attitudes, and intention. Latent variable anxiety expressed parents’ tendency 
to experience anxiety, state anxiety caused by ASD, and state anxiety caused by ASD 
genetic testing. Latent variable fear & guilt was predicted by items depicting parents’ 
fear about the social or legal implications caused by ASD genetic testing, guilt caused by 
passing down the genes associated with ASD, and guilt associated with undergoing 
genetic testing for ASD. Latent variable attitudes were predicted by three kinds of 
attitudes that included attitudes toward testing the immediate family of the affected 
children, attitudes toward carrier, prenatal, PGD, and newborn screening. Latent variable 
intention reflected the likelihood that parents might bring their child with ASD, bring 
their children without ASD, themselves, and their spouses to undergo ASD genetic 
testing. The result indicated that the model fit the data well: chi sq=2224.263, df=1109, 
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p<.001, CFI: 0.917, SRMR: 0.06, RMSEA: 0.048, 90% confidence interval (CI) for 
RMSEA [0.043, 0.049]. This model indicated that the hypothesized model provided a 
parsimonious but sufficient explanation of the observed data. 
As is shown in Figure 3, parents’ intention to undergo autism genetic testing had 
two predictors: anxiety, fear and guilt, when controlling for parents’ age, gender, 
income, and education. Anxiety (β=0.46, p<.0001) including trait anxiety, anxiety 
caused by ASD, and anxiety related to ASD genetic testing can positively influence 
parents’ intention to undergo ASD genetic testing. For instance, the greater anxiety 
parents have with regard to ASD genetic testing, the more likely they might undergo the 
test. Fear and guilt (β= -0.42, p=<.0001) appeared to negatively predict parents’ 
intention to undergo ASD genetic testing. The more fear or guilt parents have, the less 
likely they might make the decision to undergo the test. Attitudes, which were predicted 
by the three kinds of attitudes (see Figure 3) did not predict behavioral intention to 
undergo the test. Older parents appeared less likely to undergo autism genetic testing, 
whereas parents with higher incomes were more likely to undergo the test.  
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Fear and guilt  
Fear 
Guilt 1 
Guilt 2 
Attitudes Attitude A 
Attitude B 
Attitude C 
Trait 
Anxiety  
  
GT anxiety 
Anxiety 
ASD anxiety 
Intention 
Age 
Education  
Gender 
Income  
Figure 3 Testing the integrative model: final structural model of emotions, attitudes, and intention associated with undergoing autism 
genetic testing. 
 
How  
 
. .77** 
. .82** 
. .76** 
. .67** 
. .60** 
. .63** 
. .83** 
. .85** 
. .90** 
. .46** 
. -.42** 
. .00** 
. .05** 
 
N=444. CFI: 0.92; SEMR: 0.06, RMSEA: 0.04, 90 Percent C.I. [0.04-0.05] 
*p<0.05, **p<0.01.  The dash line is a non-significant path. 
 
genetic testing.  
 
How  
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Research question 2. Will the model exhibit different patterns and values 
depending on participants’ demographic information (i.e., age, gender, education, and 
income)? 
I also examined the structural variation of anxiety, fear & guilt, attitudes, and 
intention using age, gender, education and income as moderators. In order to verify the 
structural invariant, I used MLR estimators to simultaneously assess both the constrained 
and unconstrained models. The structural paths were equally restricted across 
dichotomized groups, i.e., age≥ 35 years and < 35 years, male and female, high and low 
income (≥ 40K, <40K), as well as high education and low education (college graduates 
or below college). However, none of the moderating effects of age, gender, education, 
and income yielded Satorra-Bentler scaled chi-square value. The diagnosis from the 
output indicated no convergence due to exceeded interactions. These phenomena might 
be caused by the sparse of data for the dichotomized groups. Therefore, I was not able to 
infer age, gender, education, and income interacted significantly with the latent 
variables.  
Research question 3. Which variables in the model can best predict parents’ 
intention to undergo genetic testing for ASD? Suppose both emotions and attitudes can 
predict intention, how much variability can be explained by parents’ emotions (including 
anxiety, fear, and guilt)? How much variability can be explained by parents’ attitudes 
toward testing? 
In the model, the largest predictor of intention was anxiety (β=0.46, p<.0001). In 
addition, fear & guilt were also predictors (β= -0.42, p<.0001). The use of the squared 
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multiple correlation (R2), “the percentage of variance explained by one or more 
predicator variables on a dependent variable—in SEM is an ongoing area of 
research”98(p71) and a trend in explaining social phenomena. According to the model 
results, 10% of variance in parents’ intention to undergo genetic testing for ASD can be 
explained by their emotional responses: anxiety, fear, and guilt. 
Discussion 
To the best of my knowledge, this is the first theory-driven study that examined 
emotional (anxiety, fear, and guilt) and attitudinal predictors of the intention to undergo 
ASD genetic testing among parents of children with ASD in Taiwan. The purpose of this 
study was not to promote the use of genetic testing for ASD, but to understand the 
factors that might influence parents’ decisions with regard to undergoing ASD genetic 
testing before its full implementation in Taiwan. The findings extended existing 
literature on decision-making about undergoing genetic testing for ASD in two ways. 
First, I used an integrative model and SEM analyses to understand how emotions 
and attitudes might influence parents’ intention to undergo ASD genetic testing. The 
previous literature used validated health theories, for instance, the Theory of Planned 
Behavior and the Health Belief Model, for understanding the factors predicting intention 
toward genetic testing.51 However, emotional factors have not been adequately 
addressed in these theoretical frameworks.52 Notably, this study answered the call from 
the National Health Genomics Research Institute to expand beyond the existing 
conceptual models for exploring stronger predictors of genetic test decisions.49 I added 
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affect-type variables, a largely overlooked factor in genetic testing decisions, as key 
constructs in the model.  
It is noteworthy that the findings demonstrated the negative influence of fear and 
guilt on parents’ intention to undergo ASD genetic testing. Past studies have shown that 
fear or guilt might potentially lead to a decline in genetic tests or refusal to participate in 
genetic research.92,106 The particular kind of fear or social stigma in this study was 
associated with social, legal, and ethical concerns related to testing. For instance, I 
focused on assessing fear of genetic discrimination as well as fear of social stigma 
caused by genetic testing. In addition, I specifically measured guilt caused by passing the 
ASD-associated genes onto the affected child and guilt caused by undergoing genetic 
testing. The specific kinds of fear and guilt I assessed might be attributed to the culture 
and societal factors related to having a child with genetic disabilities.106-108 
Related to the specific kind of fear and guilt I tested, the results might be 
explained by the unique Taiwanese culture and societal pressures related to having a 
child with genetic disabilities. These particular influences might play an important role 
in parents’ decisions to undergo ASD genetic testing. Unlike the Western culture, the 
Taiwanese culture is traditionally embedded within Confucianism and influenced by the 
centrality of “face.”109 Parents of children with genetic disorders might consider having a 
child with disability a family stigma. Therefore, they might be inclined to forgo genetic 
testing because testing might verify they gave birth to “an abnormal child.”77 In addition, 
similar to other Asian societies, the Taiwanese society might also demonstrate 
discriminatory attitudes toward people with mental illness.110 The findings were 
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consistent with previous studies showing that Asian cultures might significantly 
influence the decision whether to undergo genetic testing or utilize genetic services.77 
Also, autism genetic testing is still not available and officially recommended in Taiwan. 
Therefore, the feeling of fear and guilt might be caused by insufficient understanding 
about these yet-unknown tests. 
The model tested in this study demonstrated that anxiety positively influenced 
parents’ intention to undergo ASD genetic testing. The findings were in line with 
another study by Narcisa et al42 that indicated the potential for reduced anxiety was one 
primary reason for parents’ interest to be tested for ASD. The study showed that higher 
levels of anxiety were positively associated with increased likelihood of undergoing 
ASD genetic testing. This phenomenon can be potentially explained by stress and coping 
theories.111According to these frameworks, parents might consider undergoing ASD 
genetic testing as a coping mechanism.111 For this particular sample, anxiety might be a 
positive influencing factor, predicting parents’ test intention, once ASD genetic testing 
becomes available in Taiwan, researchers should examine whether testing does, in fact, 
function as a coping strategy.  
A second way that the findings contributed to the existing literature for genetic 
testing was by having direct implications for public health genomics education and 
practice. The model suggested that educational interventions might be important based 
on the identified relationships among the factors. Although the sample did not allow me 
to generalize to the entire Taiwan population, the study provided support to the need of 
pre-test counseling and genetic education among the general public in Taiwan.  
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Despite limited generalizability, the findings also informed communications 
related to ASD genetic testing among health-care providers and parents of autistic 
children. For instance, in order to provide better genetic services for families affected 
with ASD, the multi-disciplinary team involved in the diagnostic process with ASD, 
such as pediatricians and psychologists, should proactively take into consideration the 
possible emotional distress among parents of children with ASD. To effectively address 
parents’ fear, guilt, and anxiety, pre-test counseling or health education is needed; for 
example, using different modes of education such as website, DVD, lectures, and 
brochures to address negative emotions associated with the test is recommended. 
Since healthcare providers or health educators can play a critical role in shaping 
people’s decision to undergo genetic testing, it is also important to educate them and 
enhance their knowledge so that they can explain the tests to the parents of children with 
ASD. Health care providers’ insufficient knowledge regarding genetic testing has been 
well documented in previous literature.112-114 Less researched has been health care 
providers’ ability to manage patients’ emotions surrounding testing. Furthermore, to 
manage parents’ concerns resulting from fear, policymakers and legislators also need to 
consider genetic discrimination laws in Taiwan, thus, alleviating the fear of genetic 
testing for ASD and ensuring the proper use of ASD genetic services. Laws and 
regulations that prevent the genetic discrimination have been in effect in the United 
States since 2008.115 But similar regulations or laws need to be developed in Taiwan for 
protecting people from being genetically discriminated by employers or the society.  
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Moreover, race/ethnicity can be important factors that affect individuals’ 
attitudes towards genetic testing. As the study indicated, the majority of the sample has 
favorable attitudes toward ASD genetic testing and these data supported a recent study 
on attitudes toward new genetic technology in Taiwan, which indicated that the general 
public in Taiwan held a positive attitude toward genetic testing.77 Parents’ positive 
attitudes toward testing were in line with the findings from our previous study that 
showed 67% of the participants (parents of children with ASD in the United States) 
exhibited favorable attitudes toward autism genetic testing and Asian parents tended to 
be more supportive of this test.37 In this present study, I tested three kinds of attitudes: (i) 
attitudes toward testing the immediate family members of the child with ASD; (ii) 
attitudes toward carrier, prenatal, PGD and newborn screening; and (iii) lastly attitudes 
toward testing individuals with family health history. Parental positive attitudes might be 
explained by the fact that parents’ perceived benefits of ASD genetic testing outweighed 
the perceived barriers. For instance, test proponents might expect that early detection 
provides information that can be used for medical interventions that can improve the 
conditions of their autistic children.  
As discussed above, Chinese families are less likely to accept individuals with 
psychological/mental disorders. Therefore, parents might pursue genetic testing to make 
more informed reproductive decisions from ASD genetic testing. If the test results come 
positive, parents might have a high probability to terminate their pregnancies. 
Furthermore, the overall supportive attitudes toward ASD genetic testing could be 
explained by the perspectives of “eugenics” in the Asian society.116,117 The findings were 
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also consistent with prior studies indicated Chinese Americans intended to have a 
stronger likelihood of supporting genetic research.118,119 To ensure the appropriate 
utilization of ASD genetic testing, it is critical to examine the multiple factors that affect 
the decisions with ASD genetic testing prior to the provision of ASD genetic testing in 
Taiwan. 
Interestingly, the findings showed that parents were highly supportive and very 
likely to take their affected children to undergo ASD genetic testing. However, a 
favorable attitude toward testing would not affect the decisions to take the test. This 
result differed from numerous previous studies testing the key variables (attitudes and 
intention) from the Theory of Planned Behavior, which identified the strong linkage 
between people’s attitudes and their intention to undergo genetic testing.76,120,121 
There were also trends toward participants with higher annual household 
incomes having greater interest in testing. Socio-economic status (SES) has been 
reported to be related with the decisions to undergo genetic testing, and previous 
research has shown that those with higher SES are more likely to use genetic 
services.121,122 The findings indicated that heath inequities need to be addressed before 
implementing autism genetic services in Taiwan. We need to provide more resources for 
those with poor access to the genetic services and be aware of offering more affordable 
genetic services to patients with low SES.  
Several limitations of this study deserve attention when interpreting the results 
from this study. First, this is a cross-sectional study conducted among a convenience 
sample. Since the participants were recruited through teachers at public schools listed on 
 74 
 
the official website of the Department of Education in Taiwan, the sample might not 
adequately collect responses from autistic children’s parents in private schools. 
However, we did make the attempt to reach every school child’s parents in the 
designated area including private schools. Due to the location of this study, the 
generalization of the results was limited and the interpretation of these results needs to 
be considered more cautiously. Another limitation was that I only assessed pre-test 
emotional and attitudinal factors related to undergoing autism genetic testing; the future 
studies should also examine other predictors of intention, such as, perceived benefits, 
perceived barriers, and social norms. Also, although I identified that the majority of the 
parents hold positive attitudes toward genetic testing for ASD, the underlying reasons for 
parents’ optimistic attitudes should be further studied. 
Implications for Future Research 
Several implications for future study in this area are noteworthy. First, this study 
assessed the impact of anxiety, fear, guilt, and attitudes on intention. However, social 
norms, perceived benefits, perceived barriers, and perceived behavioral control might 
also have influence on parents’ intention to undergo genetic testing for ASD. Therefore, 
these factors might need to be examined further.  
Second, this study evaluated parents’ pre-test emotional responses to genetic 
testing for ASD; future studies should consider measuring both pre-test and post-test 
emotional responses when the test is available in Taiwan. In order to maximize the 
quality of counseling services and educational efforts in this research area, more studies 
are needed that focus on the specific needs of parents of children with ASD.  
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Third, the sample was a convenience sample recruited from Taiwan, thus the 
model might not be applied to other ethnic groups in other regions or countries. More 
empirical testing is needed to assess its application for parents of children in a wider 
range of geographical locations. It is of utmost importance that the theoretical model 
development should be in line with the actual understanding in diverse settings.  
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CHAPTER IV 
CONCLUSIONS 
 
The purpose of this dissertation was threefold: (i) to systematically synthesize the 
empirical literature regarding the emotional factors, attitudes, and intention associated 
with ASD genetic testing and summarize the methodological quality of the included 
studies, (ii) to examine the psychological factors, attitudes, and intention regarding ASD 
genetic testing among the sample of autistic children’s parents in Taiwan, and (iii) to 
utilize structural equation modeling analyses to examine the associations between the 
emotions, attitudes, and intention, as well as test the overall “fit” of the model in this 
study.  
This dissertation is composed of two studies that validate and support each other. 
Chapter II (the systematic literature review) informed Chapter III (the empirical study on 
emotional factors and attitudinal factors on intention to undergo genetic testing for ASD) 
in a few ways. These included the selection of targeted variables, examination of direct 
effects, and methodological quality issues, such as the use of theoretical frameworks and 
reporting of data’s psychometric properties. Results from Chapter III, in turn, supported 
and validated those of Chapter II. 
For instance, in Chapter II, a number of negative emotional factors, for example, 
fear, lack of trust, and feeling uncertain, were identified to be associated with people’s 
intention with genetic testing. Chapter III showed significant associations between 
negative emotions (anxiety, fear, and guilt) and the test intention to undergo genetic 
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testing for ASD. These results align with each other and jointly contribute to theory 
development by adding emotional predicators (such as anxiety, fear, and guilt) in the 
dominant health behavioral theories. The expanded framework better reflects empirical 
evidence and opens doors to reintegration of theories to explain decision-making 
processes related to genetic testing.  
Furthermore, as noted in Chapter II, there is a significant literature gap in the 
studies that have explored the associations between emotional factors and the genetic 
test decisions and focused on the attitude and intention for ASD genetic testing among 
the affected populations. Chapter III helped to close the gap by providing theory-based 
evidence specifically addressing the emotions, attitudes, and intention among a sample 
of 444 parents of children with ASD in Taiwan. Chapter III also confirmed anxiety, fear, 
and guilt were associated with parents’ test intention, and attitudes did not appear to be a 
factor in the decision-making process.  
This study is useful in providing insight about parents’ perspectives regarding 
ASD genetic testing prior to the full implementation of this test in Taiwan. It will also 
contribute to the development of better genetic services and research in Taiwan. The 
information revealed that it is important to design more culturally appropriate 
educational programs for parents of children with ASD in Taiwan. Most participants 
postulated favorable attitudes toward ASD genetic testing and were likely to take their 
affected children for ASD genetic testing. However, compared to the situation in the 
United States, where ASD genetic testing is offered as a routine health care service, 
there is a lack of valid and reliable ASD genetic testing procedures in Taiwan. Given 
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that the parents of children with ASD were interested in ASD genetic testing, there is an 
immediate need to develop valid and reliable testing methods in Taiwan and provide 
culturally appropriate pre-test educational interventions for parents of children with 
ASD.  
Future studies on decisions about undergoing genetic testing can benefit from 
addressing gaps in research pointed out by this dissertation. More studies are needed to 
(i) examine emotions related to the intention to undergo genetic testing for ASD among 
the affected populations; (ii) test theories that integrate emotions and other under-
investigated factors such as perceived barriers, perceived benefits, and social 
environmental factors associated with the test intention; and (iii) evaluate moderation 
effects of demographic information. Future studies will also benefit from addressing 
methodological quality dimensions, such as the employment of more rigorous designs 
and the use of comparison groups. Addressing these dimensions is crucial for achieving 
a clearer understanding of parents’ intention with regard to genetic testing for ASD for 
ASD-affected families and communities in a wider range of geographical locations. 
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APPENDIX A 
 
Characteristics of 17 Included Studies Investigating Emotional Factors, Attitudes, and Intention  
Regarding Autism Genetic Testing 
Authors Targeted 
 genetic 
tests  
  
Recruitment criteria and 
sample source 
Sample 
(N, age, ethnicity, 
education, income) 
 
Study Design 
(Method, theoretical 
framework)  
Pre-test  
counseling 
(contents) 
  
Test Uptake/ 
Acceptance 
Rate 
1.Anido et 
al. 2005  
[USA] 
Fragile X 
(FX) carrier 
screening  
 Females (18-50 years), 
both FX carriers and non-
carriers 
 University Research 
Center 
 N=40 
 Range: 21-50 years 
 Non-Hispanic White: 77% 
Non-Hispanic Black: 23% 
 Education: not reported  
 Income level: not reported 
 Qualitative: focus group 
 Theory: not reported  
 
 Yes 
 Basic disease 
characteristic 
and risks 
Not reported  
2.Anido et 
al. 2007 
[USA] 
FX carrier 
screening 
 Females (18-45 years), FX 
carriers  
 University research center 
 N=12 
 Range: 21-44 years 
 All White  
 Education: not reported  
 Income level: not reported 
 Qualitative: interviews  
 Adult Learning Theory 
Not reported Not reported  
3.Archibald 
et al. 2009 
[Australia] 
FX carrier 
screening 
 Females (≥18 years), non-
pregnant can read, speak 
or write English 
 General population  
 
 
 N=31 
 Range: 18-45 years (96.8%) 
>45 years (3.2%) 
 Ethnicity: not reported 
 College and above: 67.8% 
 Income level: not reported  
 Qualitative: semi-structured 
interviews 
 Reframed constructs from 
the Health Belief Model 
 Yes 
 Basic disease 
characteristic 
and risks 
Not reported 
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4.Archibald 
et al. 2012 
[Australia] 
FX carrier 
screening 
 Females( ≥ 16 years), 
fluent in English; affected 
relatives with first, second 
or third degree relative 
with FXS (the diagnosis is 
within one year), and 
pregnant women at <10 
weeks gestation 
 General population  
 
 N=188  
 ≥16 years 
 Ethnicity: not reported  
 Education: not reported  
 Income level: not reported 
 Qualitative: semi-structured 
interviews/focus group 
 Grounded theory  
 
 Yes 
 Knowledge or 
information 
about the 
tests 
Not reported 
5.Barley et 
al.2012 
[USA] 
 
FX carrier, 
prenatal and 
newborn 
screening 
 Both males and females 
(parents of children with 
FX) 
 General population  
 N=1099 
 Range:16-89 years 
Mean= 47 years 
 White: 92% 
Hispanic:4% 
African Americans: 2% 
Others: 2% 
 College and above: 58% 
 Income level: 56% > $75K 
 
 
 
 
 Quantitative: survey 
 Theory: not reported 
Not reported 79% preferred 
carrier testing  
6.Bailey et 
al. 2013 
[USA] 
FX newborn 
screening 
 Females (pregnant 
mothers: 59%; recent 
mothers: within past six 
months)  
 General population  
 N=118 
 Range:18-43 years 
Mean= 30.4 years 
 White: 52.5% 
African American: 39.8% 
Latino: 7.6% 
 Education: not reported 
 Income level: $50K (median) 
 
 
 Quantitative: survey 
 Theory: not reported 
Not reported 61.9%  
7.Christie et 
al. 2013 
[Australia] 
 
FX newborn 
screening 
 Females (mothers in the 
postnatal ward) 
 Clinical setting 
 N=1698 (questionnaire) 
N=173 (written documents) 
 Range: 21-30 years: 52%; >31 
years: 39%; <21 years: 9% 
 White: 88% 
Aboriginal/ Torres Strait 
Islander:7% 
Others:5%  
 Education: not reported 
 Income level: not reported 
 
 Quantitative: survey 
 Theory: not reported 
 Yes 
 Basic disease 
characteristic 
and 
information 
about the test 
94%  
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8. Cronister 
et al, 2005 
[USA] 
FX(prenatal) 
carrier 
screening 
 Females (with no known 
family history of FX 
syndrome) 
 Clinical setting 
 N=29103 
 Age: not reported 
 Ethnicity: not reported 
 Education: not reported 
 Income level: not reported 
 
 Quantitative: survey 
 Theory: not reported 
 Yes 
 Basic disease 
characteristic 
and 
knowledge as 
well as 
information 
about the test 
7.9%  
9. Fanos  
et al, 2005 
[USA] 
FX  
prenatal 
screening 
 Females (both with and 
without family history of 
FX syndrome) 
 Clinical setting 
 N=20 
 Range: 26-41years  
Mean: 35 years 
 White: 65% 
Latina:10% 
Asian:15% 
African American: 11% 
 Education: college degree 
(median) 
 Income level:$15K (median) 
 
 
 Qualitative: interviews 
 Theory: not reported 
 Yes.  
 Knowledge or 
information 
about the test 
80% 
10. Narcisa 
et al, 2012 
[USA] 
Autism 
genetic 
testing 
 Both males and females 
(parents of children with 
at least one child with 
ASD) 
 General population  
 N=162 
 Age: reported 
 White: 84.3% 
African American: 7.2% 
Hispanic: 5.7% 
Mixed: 2.9% 
 College above 93.3 %  
 Income level: 97.6% > $50K 
 Quantitative: survey 
 Theory: not reported 
Not reported 80% 
11.Johnson 
et al. 2009 
[USA] 
 
FX screening 
(other testing 
such as 
sickle cell is 
not included 
in this study) 
 Both males and females 
(church attendees) 
 Local communities  
 N=24 
 Range:18-81 years; Mean:55.26 
years (Native Americans) 
Range:18-73 years; Mean:45.67 
years (African American) 
 Native Americans: 48% 
African Americans: 25% 
 Education: not reported 
 Income level: not reported 
 
 Qualitative: focus groups 
 Reported but not further 
explained 
Not reported  Not reported 
12. Chen et 
al. 2012 
[USA] 
Autism 
genetic 
testing 
 Both males and females 
(parents of children 
 diagnosed with ASD)  
 N=42 
 Age: 44.3 years (24-58) 
 White: 50% 
 Qualitative: semi-structured 
interviews 
 Theory: not reported 
Not reported  69%  
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 Local communities Asian: 26% 
Hispanic: 14% 
Black: 7% 
Mixed: 2% 
 Some college above: 88%  
 Income level: 66.7%>$50K 
 
13. Metcalf 
et al. 2008 
[Australia] 
 
FX carrier 
screening 
  Females  
  Clinical Setting 
 N=30 (Phase I) 
N=318 (Phase II) 
N=31 (Phase III) 
 <45 years: 100% (Phase I) 
<45 years: 92.7% (Phase II) 
<45 years: 83.9% (Phase III) 
 Ethnicity: not reported  
 College diploma and above: 
66.7% (Phase 1) 
68.8% (Phase II) 
67.8% (Phase II)  
 Income level: not reported  
 
 
 Qualitative: focus group 
and interview) (Phase I and 
III) 
Quantitative: survey(Phase 
II) 
 Theory: not reported  
 Yes 
 Knowledge or 
information 
about the test 
20% 
14.Pastore 
et al. 2006 
[USA] 
FX carrier 
screening 
 Females (previous or 
current patients 
diagnosed with ovarian 
dysfunction) 
 Clinical setting 
 N=40 
 >18 years 
 White: (above 92.9%) 
 Education: not reported 
 Income Level: not reported 
 
 Quantitative: cross-
sectional survey 
 Theory: not reported 
Not reported Acceptance 
rate: 
75% (women 
with 
diminished 
ovarian 
reserve);  
42% (women 
with 
premature 
ovarian 
failure/early 
menopause)   
15.Pastore 
et al. 2008 
[USA] 
FX carrier 
screening 
 Females (diagnosed with 
diminished ovarian 
reserve before) 
 Clinical setting 
 N=20 
 Range: 32-44 years 
Mean: 39.5 years 
 White: 85% 
 Education: not reported 
 Income level: not reported 
 
 Quantitative: survey 
 Theory: not reported 
Not reported Not reported 
16.Skinner 
et al. 2003 
[USA] 
FX carrier, 
prenatal and 
newborn 
 Both males and females 
(parents of children with 
FX syndrome) 
 N=442 
 Not reported 
 White: 94% 
 Quantitative: survey 
 Theory: not reported  
Not reported Not reported 
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screening   National research centers   African Americans: 1.8% 
  Hispanic/Latino:1.3% 
  Asian: 0.6% 
  Unknown: 2% 
 College degree above:  63.9%  
 Income level: 81.7%>$51K 
 
 
17.Skinner 
et al. 2011 
[USA] 
FX 
newborn 
screening 
 Females (mothers of 
newborn within 24 hours’ 
giving birth) 
 Clinical setting 
 N=2137 
 Not reported 
 White: 43.7% 
Latino: 37% 
  Black: 4.4%  
  Other: 7.8% 
 College degree above: 36.8%  
 Income level: not reported 
 
 Quantitative: survey 
 Theory: not reported 
 Yes.  
 Knowledge or 
information 
about the test 
 63% (the 
test uptake 
rate) 
 Black 
participants 
were less 
likely to 
accept 
screening 
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APPENDIX B  
 
Distributions of emotions, attitudes, and intention of undergoing genetic testing  
among the 17 included studies 
 
Factors  Percentage Studies 
   
Emotions   
Anxiety  29.4% Archibald et al. 2013; Christie et al. 2013; Fano et al. 2006; Metcalf et al. 2008; Narcisa et al. 2012 
 
Uncertainty  29.4% Archibald et al. 2009; Archibald et al. 2013; Bailey et al. 2012; Bailey et al. 2013; Christie et al. 2013  
 
Worry  17.6% Bailey et al. 2012; Bailey et al. 2013; Skinner et al. 2011 
 
Feelings about the parent-child bonding  17.6% Barley et al. 2012; Christie et al. 2013; Skinner et al. 2011  
 
Fear  11.8% Chen et al. 2013; Johnson et al. 2009 
 
Regret 5.9% Pastore et al. 2008 
 
Angry 5.9% Pastore et al. 2008 
 
Upset 5.9% Pastore et al. 2008 
 
Grief 5.9% Anido et al. 2005 
 
Distrust  5.9% Johnson et al. 2009 
 
Frustration 5.9% Chen at al. 2013 
 
Depression  5.9% Bailey et al. 2012 
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Attitudes    
Positive Attitudes 
( Perceived benefits or outcomes) 
 
41.2% Anido et al. 2005; Archbald et al.2013; Barley et al. 2013; Chen et al. 2013; Christie et al. 2012; 
Metcalf et al. 2008; Skinner et al. 2003 
   Help with information about carrier status  29.4% Archibald et al. 2013; Bailey et al. 2013;Christie et al. 2012; Metcalf et al. 2008; Skinner et al. 2003 
   Help with reproductive choices/options  29.4% Archibald et al. 2013; Bailey et al. 2013; Chen et al. 2013; Christie et al. 2012; Skinner et al. 2003 
   Help with research  23.5% Andio et al. 2007; Chen et al. 2013; Christie et al. 2012; Metcalf et al. 2011 
   Help with early diagnosis and timely 
   medical treatment  
23.5% Bailey et al. 2013, Chen et al. 2013; Christie et al. 2012; Skinner et al. 2003 
   Help with better preparing for the birth of 
   the affected child  
 
17.6% Chen et al. 2013; Christie et al. 2012; Skinner et al.2003 
Negative Attitudes 
( Perceived barriers or outcomes) 
 
35.3% Arichibald et al. 2013; Bailey et al. 2013; Chen et al. 2013; Christie et al. 2012; Metcalf et al.2008; 
Skinner et al. 2003 
   Concerns related to the harm brought by 
   undergoing the test 
29.4% Arichibald et al. 2013; Bailey et al. 2013; Chen et al. 2013; Christie et al. 2012; Skinner et al. 2003 
   Concerns related to the characteristics of 
   the current test  
11.8% Archibald et al. 2013; Chen et al. 2013 
   Concerns related to the value of the test  11.8% Chen et al. 2013; Metcalf et al. 2008  
   Societal implications regarding the genetic 
   test 
11.8% Archibald et al 2013; Metcalf et al. 2008 
   Concerns related to religion and culture 
    beliefs  
5.9% Chen et al. 2013 
Intention or Decision-making   
 Primary reasons or outcomes for accepting 
to undergo testing 
 
52.9% Anido et al. 2007; Archibald et al. 2009; Bailey et al. 2013; Chen et al. 2013; Johnson et al. 2009; 
Metcalf et al. 2008; Narcisa et al. 2012; Pastore et al. 2006; Skinner et al. 2011  
   Perceived test benefits  52.9% Anido et al. 2007; Archibald et al. 2009; Bailey et al. 2013; Chen et al. 2013; Johnson et al. 2009; 
Metcalf et al. 2008; Narcisa et al. 2012; Pastore et al. 2006; Skinner et al. 2011  
 
   Perceived risk  23.5% Archibal et al. 2009; Bailey et al. 2013; Johnson et al. 2009;Skinner et al. 2011  
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   Subjective norms  17.6% Chen et al. 2013; Bailey et al. 2013; Johnson et al. 2009 
   Perceived barriers  17.6% Archibald et al.2009; Bailey et al. 2013; Metcalf et al. 2008 
   Emotional factor (lessened anxiety) 5.9% Narcisa et al. 2012 
 
 Primary reasons or outcomes for declining 
to undergo testing 
47.1% Archibald et al. 2009; Bailey et al. 2013; Chen et al. 2013; Johnson et al. 2009; Metcalf et al. 2008, 
Pastore et al. 2005; Skinner et al. 2011 
   Perceived barriers 47.1% Archibald et al. 2009; Bailey et al. 2013; Chen et al. 2013; Johnson et al. 2009; Metcalf et al. 2008, 
Pastore et al. 2006; Skinner et al. 2011 
      Lack of convenience  29.4% Archibald et al. 2009; Chen et al. 2013; Metcalf et al. 2008  
Bailey et al. 2013; Pastore et al. 2005 
      Issues with the current status of 
      genetic testing 
17.6% Bailey et al. 2013; Metcalf et al. 2008; Skinner et al. 2011  
      Lack of relevance 17.6% Bailey et al. 2013; Johnson et al. 2009; Skinner et al. 2011 
      Confidentiality 11.8% Johnson et al.2009; Pastore et al. 2005 
 
      Bad timing  11.8% Bailey et al. 2013; Skinner et al. 2011 
      Issues with the diseases  11.8% Bailey et al. 2013; Skinner et al. 2011 
      Cost (e.g. pay out-of-the pocket) 5.9% Pastore et al. 2006 
   Emotional factors associated with the test 29.4% Archibald et al. 2009; Bailey et al. 2013; Johnson et al. 2009; Skinner et al. 2011  
 
   Subjective norms  17.6% Bailey et al. 2013; Johnson et al. 2009; Skinner et al. 2011 
 
 
 
